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ABSTRACT 
Introduction: Oxygen delivery, or utilization, is a function of retinal blood flow and blood oxygen 
saturation. The retinal pigment epithelium (RPE), in particular, has been shown to have the highest levels 
of metabolic activity within the human body. Oxygen delivery is therefore of extreme importance to the 
maintenance of the health and integrity of the retina. 
Animal models presuppose that the oxygen tension in the retina is highest in the innermost layers at the 
level of the choriocapillaris, less in the photoreceptors and further decreases throughout the outer retinal 
structures. The choroid provides by far the largest component of the oxygen for consumption by the 
photoreceptors. A lack of oxygen stores in the inner retina therefore makes a constant supply crucial for 
its normal functioning. Blood flow dysfunction and subsequent hypoxia are both a feature in the 
pathogenesis of several major ocular diseases such as retinopathy of prematurity (ROP), age-related 
macular degeneration (ARMD), diabetic retinopathy (DR) and glaucoma. The development of methods to 
measure retinal blood flow and blood oxygen saturation is crucial to improve understanding of the patho-
physiology of major ocular diseases.  
Purpose: The aims of this work were, firstly, to determine the least variable (range ± standard deviation) 
wavelength combination (610/548, 600/569 and 605/586) and subsequent ODR with the prototype HRC 
device. Secondly, using the ODR with the lowest measurement variability, we sought to quantify retinal 
blood SO2 in arterioles and venules and investigate the relationship between retinal blood SO2 and total 
retinal blood flow (TRBF) in response to stepwise changes in PETO2 in healthy participants. Retinal blood 
SO2 and TRBF were assessed using the IRIS HRC (Photon etc. Inc. Montreal, Canada) and the RTvue 
Doppler Fourier Domain OCT (Optovue Inc, Freemont, CA) instruments, respectively. 
Methods: Ten healthy participants between the ages of 23 and 37, with an average age of 28.3 years were 
evaluated in two descriptive cross-sectional studies. Two gas provocation protocols; hyperoxia (end-tidal 
oxygen; PETO2 of 100, 200, 300, 400mmHg) and hypoxia (PETO2 of 100, 80, 60, 50mmHg) were 
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administered in a fixed sequential order. In each phase of gas provocation (via modulation of P ETO2), 
retinal blood SO2 and TRBF measurements were acquired with the HRC and Doppler FD-OCT. The 
precise and repeated control of the partial end tidal pressures of oxygen (PETO2) and carbon dioxide 
(PETCO2) over the pre-determined phase duration, irrespective of the individuals’ respiratory rate, was 
made possible with the RespirAct (Thornhill Research Inc., Toronto, Canada); a sequential re-breathing 
gas delivery  
Results: In arterioles, the group range (±SD) of ODR values for baseline measurements (P ETO2 of 
100mmHg) was 0.169±0.061 for the 605/586 wavelength combination, 0.371±0.099 for the 600/569 
wavelength combination and 0.340±0.104 for the 610/548 wavelength combination.  In venules, the 
group range (±SD) of ODR values was 0.600±0.198 for the 605/586 wavelength combination, 
0.569±0.169 for the 600/569 wavelength combination and 0.819±0.274 for the 610/548 wavelength 
combination. With the 605/586 combination at baseline 1 and 2 in arterioles, the group range (±SD) of 
ODR values was 0.607 ± 0.224 and 0.619 ± 0.158, respectively (p = 0.370), while in venules the group 
range (±SD) of ODR at baseline 1 and 2 was 0.289±0.750 and 0.284 ± 0.729, respectively (p = 0.714). 
For the 600/569 combination at baseline 1 and 2 in arterioles, the group range (±SD) of ODR values was 
0.747±0.350 and 0.761±0.391, respectively (p = 0.424) while in venules the group range (±SD) of ODR 
at baseline 1 and 2 was 0.329±0.675 and 0.366±0.659, respectively (p = 0.372). For the 610/548 
combination at baseline 1 and 2 in arterioles, the group range (±SD) of ODR values was 0.604±0.263 and 
0.685±0.450, respectively (p = 0.056) while in venules, the group range (±SD) of ODR at baseline 1 and 
2 was 0.292±0.746 and 0.285±1.009, respectively (p = 0.131). There was no statistical difference found 
between baseline ODR values (baseline 1 and 2) across all three wavelength combinations in both 
arterioles and venules.  
The mean retinal blood SO2 value at baseline in arterioles for 4 participants was 95.19% ± 31.04% and 
venules was 53.89% ± 17.24% (p = 0.115). There was a negative linear relationship between group retinal 
blood SO2 and TRBF values in the 10 participants studied, although the results of any of the 10 
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individuals did not show evidence of such a relationship using the described methodology. The Pearson’s 
correlation coefficient (r) between TRBF and SaO2 was r = -0.354 and p = 0.001 and between TRBF and 
SvO2 was r = - 0.295, p = 0.008 
Conclusion:  Of the three wavelength combinations investigated (605/586, 600/569 and 610/548), the 
605/586 combination was shown to have the overall least variability. It would be unwise at this stage to 
adopt this wavelength combination for clinical usage, however, since it is presupposed that the 605/586 
combination is also the most reliable combination to detect change in retinal blood SO2 i.e. lower 
variability of the 605/586 combination may be irrelevant if this combination proves to be insensitive to 
change in retinal blood SO2. The absolute mean ± SD retinal blood SO2 in the arterioles (SaO2) was 
95.19% ± 31.04% and in the venules (SvO2) was 53.89% ± 17.24%. These values fell within the range 
expected and described in the literature. The magnitude of the difference between the SaO2 and SvO2 was 
also consistent with the literature. These findings were all appropriate for a low flow, high oxygen 
exchange vascular network typical of the inner retinal vascular system. Using group rather than individual 
data, TRBF was found in this study to relate inversely with SaO2 (r = -0.354 and p = 0.001) and SvO2 (r = 
– 0.295 and p=0.008), respectively. This relationship between TRBF and SaO2 and SvO2, was as expected 
based upon data derived primarily from animal models. This study is ground-breaking and unique, in that, 
it is the first study to concomitantly measure both retinal blood SO2 and TRBF in human participants. 
Individual data showed extensive variability and noise, thus limiting the strength of the association 
between TRBF and SaO2 and SvO2.. 
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1 Introduction 
Vascular reactivity (VR) is the magnitude of change of the diameter of blood vessels, velocity or blood 
flow to provocative stimuli, such as the partial arterial pressures of carbon dioxide (PaCO2) or oxygen 
(PaO2) in the blood. VR data provides the opportunity to look at more parameters regarding our blood 
flow information and the magnitude of changes observed do not require large sample sizes. Several 
studies have demonstrated the disturbance of VR due to disease with various provocative stimuli 
including such as CO2, O2 and flicker 
1-4
.  
Oxygen saturation (SO2) is the measure of the percent amount of hemoglobin (Hb) bound to oxygen in 
blood. Oximetry; the method of measuring SO2, is measured in our lab with spectroscopic techniques 
such as pulse oximetry (finger and ear oximeters) which measures the absorbances due to the pulsaltile 
nature of arterial blood alone in systemic SO2. Retinal SO2 on the other hand is measured with a two 
wavelength oximetry method, using a prototype digital hyperspectral device for imaging the retina. This 
method was first developed by Beach and co-workers (1999) 
5
 in the late 90’s. 
Several noninvasive methods of measuring retinal blood flow (RBF) have been developed over the years 
such as color doppler imaging, fluorescein angiography and laser doppler velocimetry and flowmetry 
techniques among others. The Doppler Fourier Domain OCT (FD-OCT) allows for the quantification of 
Total Retinal Blood Flow by applying bidirectional laser doppler velocimetry methods. Retinal blood 
flow is related to SO2 in that hemoglobin is carried by the blood.  
The measurement of retinal blood SO2 is plagued with several difficulties such as the scattering of light in 
retinal tissues due to the discontinuities in the refractive indices between the plasma, red blood cells and 
other components of whole blood; and the variation in fundus pigmentation with ethnicity 
6-9
. Despite the 
numerous challenges faced by retinal oximetry, several methods have been developed over the decades 
that compare the absorbance spectra of oxyhemoglobin (HbO2) to that of deoxyhemoglobin (Hb) and then 
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derive the optical density ratio (ODR) and retinal blood SO2. These technologies devised for the 
measurement of retinal SO2 show promise in the earlier detection of hemodynamic changes in the retina 
which has been shown to be affected in several major ocular diseases such as glaucoma, diabetic 
retinopathy and age-related macular degeneration 
10-13
. Indeed, methods of measuring retinal SO2 bring 
scientists significantly closer to a fuller understanding of the processes involved in retinal diseases with 
hemodynamic components. 
1.1 The Vascular Systems of the Human Retina  
The human ocular circulation is multifaceted and unique. This uniqueness is primarily due to the presence 
of a dual vascular system; the retinal and choroidal systems. Since the middle of the 19
th
 century, several 
non-invasive methods have been developed for studying various aspects of ocular hemodynamics and its 
response to stimuli of a physiological and pharmacologic nature. These methods have enabled advances 
into understanding the physiology of ocular blood flow and also greater awareness of its disturbance in 
several systemic and ocular diseases. 
1.1.1 Anatomy of Retinal Vessels  
Retinal arterioles and venules are made up of 3 layers; adventitia, smooth muscle cells, and endothelial 
cells. The adventitia forms the outermost layer of the vessel and the endothelium the innermost. Retinal 
capillaries on the other hand, are composed of only endothelial cells which are surrounded by a basement 
membrane which contains pericytes arranged in a laminar fashion.  
Arterioles, termed “resistance” vessels, together with the central retinal artery (CRA) are thought to be 
responsible for the major regulation of the flow of blood to the capillaries 
14
. The capillaries are 
responsible for the exchange of metabolites (“exchange” vessels) with the tissues and, via the contractile 
properties of the pericytes, are thought to play a minor role in the fine tuning of retinal perfusion 
14-16
. The 
inner blood retina barrier (BRB) is made up of numerous tight junctions between the endothelial cells 
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lining the retinal blood vessel lumen. At the level of the capillaries, the BRB prevents leakage of blood 
constituents into the retinal tissue but does allow transfer of oxygen across the vessel wall. The 
endothelium and its associated tight junctions are often collectively termed the inner BRB. 
Blood vessels of both the choroid and retina of human ocular circulation take their source from the first 
branch of the internal carotid artery known as the ophthalmic artery (OA) which has several branches 
including the CRA, the short and long posterior ciliary arteries (PCA), and the anterior ciliary arteries 
(ACA).  Choroidal and retinal vessels differ both morphologically and in their purposes from each other. 
Retinal vessels are non-fenestrated and have a narrower lumen than choroidal ones which provide less 
resistance to blood flow. The flow of blood is low in the retina, subsequently allowing for a higher 
extraction of oxygen with an arteriovenous saturation difference of about 40% 
17, 18
. The choroidal system 
on the other hand has a high blood flow rate, representing 85% of the total ocular blood flow 
19
 and a low 
oxygen extraction of 3% 
20
. Fenestrations in the choroidal capillaries facilitate the high rate of blood flow 
and the exit of retinol-binding protein which allows retinol (vitamin A) to reach the retinal pigment 
epithelium (RPE) 
21
. The choroidal capillaries also provide the RPE with all the building blocks of 
phototransduction such as amino acids, proteins and oxygen and are responsible for the removal of waste 
products from the RPE. Choroidal vessels, unlike retinal capillaries also leak plasma proteins. The RPE 
forms the outer BRB through its role of selectively transferring retinol from its carrier protein to the retina 
while preventing the diffusion of plasma proteins 
22
. In addition, the tight junctions of the RPE cells and 
the selectively permeable cell membrane determine the exchange features of the outer BRB. 
1.1.2 The Retinal Vascular System  
The inner two-thirds of the retina receive its supply of oxygen and metabolites from the terminal 
arterioles without anastomoses. After emerging from the optic disc 10-15mm behind the globe, the CRA 
divides into two major branches and then into arterioles which each supply a quadrant of the inner retina 
(layers closest to the vitreous compartment). The arterioles form an anastomotic capillary plexus which 
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supply the nerve fiber, ganglion cell and inner nuclear layers of the retina. The single layered capillaries 
extend to the periphery of the retina. At the extremes of the peripheral retina, there is a noticeable  
avascular, capillary free zone either side of the arterioles that runs parallel with the vessel course and can 
be up to approximately 1.5mm wide 
23
. The foveal avascular zone (FAZ) is supplied primarily by the 
underlying choroidal and to a lesser extent the surrounding retinal capillary network of vessels. In about 
25% of human eyes the macular region of the retina will also be perfused by the cilioretinal artery 
emerging from the temporal margin of the optic disk 
24
. Inner RBF constitutes only about 4% of total 
ocular blood flow 
23
.  
1.1.3 The Choroidal/Uveal Vascular System 
The PCAs and ACA form the vessels of the choroid and supply the uvea and outer and middle layers of 
the retina after entering the globe around the optic nerve, forming paraoptic and perimacular patterns 
25
. 
The major arterioles of the choroid are formed from the subsequent branches of the short PCAs 
26, 27
. 
1.1.4 Differences in the Choroidal & Retinal Vascular Systems  
It has been demonstrated previously that retinal blood flow (RBF) is significantly slower with subsequent 
increased oxygen exchange than choroidal blood flow in the outer retina 
28
. The low rate of flow of blood 
in the inner retina makes it much more susceptible to interruptions in blood supply as compared to the 
choroidal system 
29, 30
. The arteriovenous difference in blood oxygenation extraction in the retina is 35% 
as compared to only ~4% in the choroid 
31
. The retinal circulation lacks sympathetic innervation, unlike 
the choroid, and it is influenced by intrinsically released local factors 
22
. A further difference between the 
choroidal and retinal systems is the thermoregulatory property of the choroidal vessel network which in 
effect cools the metabolically active pigment epithelium- photoreceptor complex. 
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1.1.5 Venular Drainage  
After running its course in the globe, deoxygenated blood drains from the eye through the venules and 
veins primarily via the vortex veins, the central retinal vein and finally the ophthalmic vein. The central 
retinal vein exits the globe with the optic nerve parallel and against the flow of the CRA 
32
. 
1.2 Regulation of Ocular Blood Flow in the Human Retina 
Local and systemic factors play a role in the rather complex regulation of blood flow in the eye. 
Generally, local factors such as O2 tension (PO2), CO2 tension (pCO2) and pH adjust the flow based on 
local needs, while systemic factors such as circulating hormones and the autonomic nervous system 
(ANS) adapt the distribution of the cardiac output over the different vascular beds depending on the 
general blood flow needs of the body 
22
.  
The cardiac cycle consists of the period from the end of one heart contraction to the end of the next. With 
a period of relaxation called diastole, followed by a period of contraction called systole. Arterial pressure 
has a pulsatile nature due to the intermittent pumping of blood by the heart. Cardiac output is the quantity 
of blood pumped by the heart in a unit period of time and is about 5 liters/minute 
20
. 
Chocolate 
33
, dynamic and isometric exercise 
34-37
, smoking 
1, 38, 39
 , alcohol (ethanol) 
40, 41
 caffeine 
42
, high 
fat diets 
43
, hyperglycemia 
42, 44-46
 and vitamin C 
47
 intake have been shown to alter retinal hemodynamics 
of humans. 
1.2.1 The Rate of Blood Flow 
The rate of blood flow (F) is the volume of blood that passes a given point in the vasculature at a given 
point in time. Blood flow is normally expressed in microlitres per minute (μl/min) 20. The rate of blood 
flow in a vascular bed depends on two main factors; the perfusion pressure gradient (ΔP) over the 
vascular bed and the resistance to flow (R) within the vascular bed (Ohm’s/Darcy’s Law) 22.  
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 …………………………1 
Where, R depends on blood viscosity (η), the vessel length (L) and diameter (2r) of the blood vessels.   
Using steady blood flow conditions through a cylindrical rigid tube, R is directionally proportional to 
blood viscosity (η) and the length (L) and inversely proportional to the fourth power of the radius (r) of 
the vessel;  
…………………………….2 
Or as stated in the Law of Poiseuille: 
…………………………….3 
The contraction and relaxation of the arterioles modifies the blood resistance, R.  
Poiseuille’s equation serves as a useful approximation for blood flow calculation; however, it possesses a 
few limitations for use in the cardiovascular system. Unlike the rigid tubes used by Poiseuille, the 
elasticity and tapering structure of the human vessels, lack of laminar flow in some larger vessels, 
pulsatile flow resulting from heart contractions and the variability of blood viscosity with velocity 
(deviation from a perfect Newtonian fluid) all serve as departures from the standards used to derive 
Poiseuille’s equation 48. 
1.2.2 Ocular Perfusion Pressure (OPP) 
OPP is the pressure that drives blood through a vessel and is calculated as the difference between the local 
arterial blood pressure and the venous pressure. Venous pressure is not easily calculated however, it has 
been shown to be only slightly higher than intraocular pressure (IOP). IOP therefore serves as a good 
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surrogate for venous pressure and has since been widely accepted as the standard 
49
. OPP is thus 
calculated as follows: 
…………………………4 
Where, BPmean is the mean arterial blood pressure and IOP is the intraocular pressure 
50, 51
. 
1.2.3 Vascular Resistance (R) 
Vascular resistance generated by friction between the moving blood and vessel wall cannot be measured 
directly. Increases in arterial pressure have been shown to not only increase the force that tends to push 
blood through the vessels, but to also distend the vessels concurrently, which decreases their resistance 
20
. 
However, vascular resistance is influenced by a number of factors such as the blood viscosity, length and 
diameter of the vessels.  
1.2.3.1 Blood Viscosity (µ) 
Blood viscosity is the measure of the resistance of blood to flow and is the major determinant of the shear 
stress imparted by blood flow 
52
. The viscosity of blood plays an important role in maintaining vascular 
homeostasis and varies as a function of the shear rate; increasing at low shear rate due to the ‘Rouleaux’ 
effect of the red blood cells (RBCs) and diminishing to an almost constant rate at high shear rate. Shear 
rate can be described as a force or pressure acting on the blood which may cause blood layers to slide past 
each other at a certain velocity altering its shear rate. An increase in shear stress acting against vessel 
walls increases the shear rate. The ‘Rouleaux’ effect describes stacks of RBCs formed as a result of the 
large surface area of the cells which allows adhesion to each other due to the unique discoid shape of the 
cells in vertebrates. In certain diseased states, substantial changes occur in the blood velocity 
53
. 
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1.2.3.2 Vessel Length (L) 
Changes in the length of vessels appear to be of little significance in the regulation of ocular circulation. 
This is due to the constant state of perfusion of the ocular capillaries compared to capillaries found in 
other parts of the body e.g. capillaries of the pulmonary circulation 
22
. 
1.2.3.3 Vessel Diameter (2r) 
Variation in diameter is the main regulatory mechanism of ocular circulation. Slight changes to the 
diameter of a vessel cause substantial changes to resistance and blood flow as vascular resistance, R is 
inversely proportional to the fourth power of the radius of a blood vessel. Both systemic and local factors 
can trigger a change in vessel diameter 
22
. The change in diameter of the vessels is also directly related to 
the blood velocity. This relationship applies to arterioles and venules. Blood flow touching the wall of 
large vessels (laminar flow) is extremely slow compared to that near the center of the same vessel due to 
its adherence of RBCs to the vascular endothelium. This is not the case in vessels of smaller diameter, 
where essentially all of the blood flow is in contact with the wall. The blood velocity therefore remains 
relatively constant throughout the vessel. For a specific vessel diameter, the blood flow rate and velocity 
in a retinal arteriole is greater than in the retinal venule 
20
. The rate of blood flow, F, that flows through a 
vessel in a given period of time is equal to the velocity of flow times the cross-sectional area 
54
; 
…………………….5 
Where F is the rate of blood flow (µl/s ) and  is the cross-sectional area (cm
2
) 
1.2.4 Autoregulation  
Myogenic autoregulation is “the ability of a vascular bed to keep blood flow constant despite changes in 
perfusion pressure (PP)”. Alternatively, metabolic autoregulation is “the ability of a vascular bed to 
change blood flow to meet metabolic needs” by the constriction or dilation of retinal vessels 55. 
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Myogenic, metabolic stimuli and endothelium-derived vasoactive factors regulate RBF by influencing the 
tone of the muscles in the retina and choroid. Vasoconstriction is promoted by calcium ion movement into 
the smooth muscle cells which reduces blood flow in order to avoid hyper-perfusion, capillary damage 
and edema 
56
. The opposite is also true with vasodilation as a result of potassium ions producing a 
reduction in perfusion pressure (PP). The myogenic regulation of blood flow alters blood flow resistance 
so that the blood supply maintains the concentrations of certain metabolites and waste-products within 
narrow limits (principally the PO2 and PCO2) 
11
. An increase in PP results in an increase in transmural 
pressure which leads to a distension of the blood vessel wall and the myogenic contraction of retinal 
arteries 
57
. The autoregulatory process of the retinal and optic nerve head (ONH) blood flow holds only if 
PP is not reduced by more than 50 percent 58, 59. 
1.2.5 Blood Gases 
When otherwise healthy individuals inhale mixtures of 100% oxygen or co-administered 90% oxygen and 
5% CO2, it leads to an increase in partial pressures of oxygen (PO2) in the arteries resulting in hyperoxia 
60, 61
. Hyperoxia elicits a vasoconstriction of retinal blood vessels and significant decrease in RBF in the 
macular and peripheral retinal regions of the retina 
62-65
. A full, vasoconstrictor reponse to hyperoxia 
stabilizes after 6 minutes 
62
, Vasoconstriction of the retinal arterioles serves as a regulatory response for 
keeping the PO2 in retinal blood constant. Reduced retinal capillary and ONH blood flow has been seen in 
smokers, secondary to hyperoxia 
66
. During breathing of 100% O2, the retina receives added O2 from the 
choroid due to a reduction in blood flow in the retina. 
Hypoxia is a state of abnormally low PO2, resulting in an increase in RBF to maintain a stable PO2 
environment and vasodilation in the inner retina which may be due the secretion of retinal lactace 
67, 68
. 
Lactacte is believed to be mediated by endothelium-derived Nitric Oxide (NO) 
69
. Hypoxia of the retina 
causes vasodilation of the retinal arterioles beginning at hemoglobin (Hb) SO2 below 90% and can be 
measured clearly below 65mmHg 
61, 70
.  
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In conditions of normoxia (baseline) in healthy participants, PaO2 and PaCO2 values vary depending on a 
number of biological factors such as gender, height, weight, age and medical history. Generally speaking, 
however, PaO2 values vary between about 75-100mmHg (10-13kPa) 
71
 and PaCO2 about 34-45mmHg 
(4.5-6.0kPa) 
72
. Isocapnia is a state in which the arterial carbon dioxide pressure remains constant of 
unchanged. 
1.2.6 Endothelial Derived Factors  
The vascular endothelium produces various vasodilating and vasoconstricting mediators under basal 
conditions and in response to stimuli from mechanical sources in the form of stretch receptors within the 
smooth muscle cells that respond to changes in trans-luminal pressure
73
 and chemical (e.g. acetylcholine - 
ACh, histamine and calcium ionophores). Endothelial locally derived factors can be divided into two 
groups; endothelial derived relaxing factors (EDRF) and endothelial-derived contracting factors (EDCF). 
Prostaglandins are also vasoactive factors released by the endothelium which may elicit both 
vasoconstriction and vasodilation. Prostaglandins have been shown to disrupt the internal BRB thus 
causing an increase in the permeability of retinal capillaries and may have a significant role in the 
regulation of choroidal and retinal circulation 
22
. Blood flow is locally regulated by these vasoactive 
factors derived from the endothelium when they act upon the smooth muscle cells (surrounding the 
endothelial cells) and the pericytes (that surround the capillaries). The hemodynamic regulatory property 
of the endothelium may be disrupted by many vascular diseases such as ischemia and reperfusion, 
hypertension, hypercholesterolemia and diabetes. Therapeutic agents can be used to trigger the secretion 
of vasoactive substances by the endothelium 
74
.  
1.2.6.1 Endothelium Derived Relaxing Factors (EDRF) 
Nitric oxide (NO) is one of the most important endothelial relaxing factors 
75
. It is formed from L-arginine 
by NO-synthase and has been shown to be released continuously by the endothelium of the ophthalmic 
76
and retinal arteries 
77
.  NO release can be stimulated by a variety of endogeneous substances such as 
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acetycholine, bradykinin, noradrenaline and histamine 
77-80
, in response to an increase in shear stress 
81
 
and platelet-derived products such as adenosine diphosphate, serotonin, thrombin 
80
. This relation to shear 
stress is more likely however in larger conduit arteries 
22
. NO is produced also in response to changes in 
trans-luminal pressure and shear stress. NO induces vasodilation by increasing cyclic guanidine 
monophosphate that in turn reduces calcium ion concentration (Ca
2+
) in smooth muscle cells resulting in 
relaxation and subsequent dilation 
82
. NO also inhibits platelet function Vasoconstriction results when NO 
is inhibited. 
Prostacyclin (PGI2, ecoprostenol) is also an endothelium secreting vasodilator. It also inhibits platelet 
aggregation 
83
 and  is produced from arachidonic acid via the activation of the enzyme cyclooxygenase 
84
 
1.2.6.2 Endothelium Derived Constricting Factors (EDCF) 
Endothelin-1 is a large 21 amino acid peptide present in almost all blood vessels 
20
. The endothelin family 
is comprised of 3 polypeptides that are all important in vascular regulation; endothelin-1 (ET1), 
endothelin 2 (ET2) and endothelin 3 (ET3). ET1 is the most potent vasoconstrictor secreted by the 
endothelial cells 
85
 which at higher concentrations causes vasoconstriction and vasodilation at low 
concentrations 
86
. The vasodilatory response to endothelin involves the activation of endothelial receptors 
(ETB-type) linked to NO and/or prostacyclin released by the endothelial cells 
87
. On the other hand, 
vasoconstriction results from the activation by endothelin of specific membrane receptors ( ie. ETA- and 
ETB- receptors) on the smooth muscle cells 
88
. Receptors for endothelin-1 have also been reported on 
choroidal and retinal arteries 
22
. Vasoconstriction results in a reduction of RBF after intravenous 
administration of ET1 and occurs secondary to increased intracellular Ca
2+
 
23, 89
. NO inhibits the release of 
ET-1
90
 while ET-1 impairs NO bioavailability resulting in a self-limiting mechanism that inherently limits 
the vasoactive properties of ET-1 and NO. Shear stress down-regulates endothelin synthesis 
91
. 
Endothelin-1 and the endothelin-A receptor have been reported to play a role in the retinal hemodynamic 
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responses to hyperoxia 
92
. Other EDCFs such as thromboxane A2, prostaglandin H2 or superoxide anions 
are produced by the cyclooxygenase pathway of the endothelium  
1.2.6.3 The Interaction of EDRFs and EDCFs in the Regulation of Ophthalmic Circulation 
The ophthalmic circulation is maintained in a constant state of vasodilation due to the constant basal 
release of NO in the ophthalmic vascular bed.  Stimulated release of NO occurs as a result of agonists 
such as bradykinin, acetylcholine and histamine mediated by receptors 
74, 79, 92
. Inhibitors of NO formation 
such as L-NMMA or L-NAME reduce the responses to these agonists. EDRFs are essential especially in 
small vessels and possibly in the microcirculation. This has been demonstrated in vitro in extraocular pig 
vessels in which the sensitivity to the agonist bradykinin increases as the diameter of vessels reduces 
93
. In 
addition, both constriction and dilation of the vessels occur with certain agonists such as histamine (e.g. 
histamine interacting with H1-histaminergic receptors inducing both NO mediated relaxation and a 
contraction when acting on smooth muscle cells) when it activates the endothelial or smooth muscle cells.  
Endothelin-1 and 3 at lower doses elicits the release of prostacyclin – causing vasodilation at lower doses 
and reduced flow and vasoconstriction at higher concentrations of endothelin-1. ETB-receptor is activated 
at very low doses of endothelin-1. On the other hand, the ETB-receptor is activated predominantly at 
higher doses of endothelin-1 on smooth muscle cells 
70, 94
. 
The inner retinal blood flow system may be influenced by a number of systemic regulatory systems and 
factors in various organs such as hormonal, pharmaceutical, ions and other chemical factors.  
1.2.7 Other Influences on Retinal Blood Flow 
1.2.7.1 Hormonal Influences 
Vasoactive hormones influence blood flow through two main mechanisms; the mediation of the 
endothelial cells and directly on the smooth cells and pericytes of blood vessels 
95
. 
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1.2.7.1.1 Renin/Angiotensin 
Angiotensin II, a highly active octapeptide is a potent vasoconstrictor of ocular vessels formed by 
angiotensin-I which is activated by the angiotensin-converting enzyme (ACE) 
20, 96
  
1.2.7.1.2 Norepinephrine and Epinephrine 
Norepinephrine and Epinephrine are vasoconstrictors; with norepinephrine being more powerful than the 
latter. Epinephrine can cause mild vasodilation. Norepinephrine is released by sympathetic nerve endings 
in individual tissues when the sympathetic system of the body is stimulated during stress or exercise 
which stimulates α-receptors and β-recetors (in the case of vasodilation in certain vascular beds) and 
contracts veins and arterioles 
20, 96
. The adrenal glands also secrete norepinephrine and epinephrine by the 
sympathetic nerves to the adrenal medulla. Choroidal vessels are constricted by catecholamines found 
circulating in the blood 1499 
96
. 
1.2.7.1.3 Vasopressin 
One of the body’s most potent vascular constrictor substances is vasopressin (also called antidiuretic 
hormone). It is a more powerful vasoconstrictor than angiontensin II. Vasopressin is formed in the nerve 
cells in the hypothalamus of the brain and transported downwards to the pituitary gland by nerve axons 
where it is secreted into the blood 
20
. 
1.2.7.1.4 Natriuretic Peptide 
Natriuretic peptides (atrial natriuretic peptide, C-type natriuretic peptide and brain natriuretic peptide) are 
produced in cardiocytes and vascular endothelial cells and may be considered a part of the renin-
angiotensin system. Natriuretic peptides have a vasodilatory effect on vessels. 
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1.2.7.1.5 Ions and Other Chemical Factors 
1.2.7.1.5.1 Vasodilatory Effects 
An increase in potassium, magnesium (inhibits smooth muscle contraction) and hydrogen ions (decrease 
in pH), acetate and citrate anions and carbon dioxide (marked vasodilation in the brain, moderate 
vasodilation in the tissues) concentration causes vasodilation 
20
. 
1.2.7.1.5.2 Vasoconstrictor Effects 
An increase in calcium ion (stimulates smooth muscle) and decrease in hydrogen ion concentration causes 
arteriolar constriction 
20
. 
 
1.3 Optical Coherence Tomography 
Optical Coherence Tomography (OCT) 
97
 provides a non-invasive, non-contact method of providing high-
resolution cross-sectional imaging of human tissues such as the retina 
98-101
 and is commonly used in the 
diagnosis and management of retinal diseases and glaucoma
102-106
. The optical configuration of OCT is 
that of a low coherence (white light) interferometer 
107
. OCT technology emerged from in vivo optical 
length measurements of the eye with low coherence interferometry 
108
. 
1.3.1 Overview of OCT 
OCT relies on the interference between a split and subsequently re-combined broadband optical field. The 
split field travels in the reference arm of the system, reflecting from a reference mirror, and also in a 
sample arm where it is reflected from several layers within a sample tissue. Interference between the 
optical fields is only detected when the reference and sample arm optical path lengths are coordinated to 
within the coherence length of the light, due to the broadband nature of the light used. The depth or axial 
resolution of the OCT therefore is determined by the temporal coherence of the light source. Differences 
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in refractive index between layers in the sample tissue of interest manifest themselves as consistent peaks 
in the interference pattern 
109
. A schematic of a typical OCT system is shown in figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Basic OCT system, based on Michelson interferometer 
 
1.3.2 Types of OCT 
OCT can be classified into two broad groups based on its design components. These are the time domain 
OCT (TD-OCT) and frequency domain OCT (FD-OCT) systems. 
1.3.2.1 Time-Domain OCT 
The TD-OCT system has a reference mirror which is scanned along the z-axis to match the optical path 
from reflections within the sample. Light that carries a signal returning from the eye interferes with light 
that has travelled a known path length. The moveable nature of the reference mirror is the most essential 
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and unique feature of the TD-OCT 
110, 111
. A time-domain interference pattern formed displays a 
reflectivity profile (with spatial dimension details of the tissue) in the form of axial scans (A-scans) which 
is then further combined to form a cross-sectional tomograph. Commercial OCT instruments have been 
developed for ophthalmology based on the TD-OCT system 
109, 111
. 
 
Figure 1.2  Schematics of time-domain OCT. The reference mirror (upper right) is moveable over a 
distance that corresponds to the axial (depth) range of interest in the sample. Reproduced with 
Permission. 
112
 
1.3.2.2 Frequency Domain OCT  
The reference optical path length remains fixed with the FD-OCT system and component frequencies of 
the OCT output are detected with a spectrometer 
109, 113
. The lack of moving parts in the system are an 
advantage of the system in that it allows for rapid image acquisition and a greater signal to noise ratio 
108, 
113, 114
. The presence of a fixed mirror is one of the major advantages and differences that FD-OCT has 
over the TD-OCT which has an adjustable mirror. The intensity spectrum determined is converted by 
Fourier techniques into the time domain to recreate the depth resolved sample optical structure 
109
. 
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Figure 1.3  Schematic diagram of a spectrometer-based Fourier-domain OCT system. It contains a stationary reference 
mirror and a spectral interferogram (spectrum of the combined reference and sample reflections). Spectral modulations 
of difference periodicities are formed from reflections from different depths of the sample. A Fourier Transform converts 
spectral modulations into an A-scan. Reproduced with Permission. 112 
 
1.4 Quantification of Retinal Hemodynamics  
The first attempt at quantifying hemodynamics in humans in response to alterations in PO2 in the retina 
was made by Hickman and Frayser in the 80’s with the bidirectional laser Doppler velocimetry 
methodology
115
. Since then, the development of methods of quantifying ocular hemodynamics in humans 
and animals has been ongoing over several decades and has led to several technologies of varying 
efficacy. Initial methods carried out experimentally were of an invasive nature and tested on animals. 
These invasive methods included the cannulation of uveal veins in rabbits and cats 
116
 to directly measure 
blood flow and labelling microspheres radioactively 
19
. In more recent years however, non-invasive 
methods have been advanced that are applicable and safe for use on humans. These methods focus on the 
measurement of retinal hemodynamic parameters such as the diameter (D) of retinal vessels, mean 
circulation or transit time (MCT or MTT) of fluorescein injected intravenously through a retinal segment 
from entry to exit of microvascular segment 
117
, arteriovenous passage time (AVP); the time difference 
between the first appearance of the dye at a reference point at the temporal artery and that at the adjacent 
vein 
118
. For several years, the bidirectional laser Doppler velocimetry (BLDV) methodology was the only 
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technology that was capable of measuring absolute blood flow velocities, prior to the introduction of 
Doppler FDOCT. However, the high costs involved with purchasing BLDV systems for routine use by 
practitioners has prevented the method from being introduced on a large scale for routine clinical use and 
as a gold standard for the quantification of blood flow.  
1.4.1 Retinal vessel analyzer (RVA) 
Diamter has been measured in the past with the use of magnified fundus photographs using a caliper or 
scanning across the vessels 
119, 120
. This technique however was improved and simplified by the use of the 
Retinal Vessel Analyzer (RVA) allowing the additional possibility for dynamic measurements of diameter 
121-123
. Making use of the brightness profile of the vessel, RVA measures the diameter of vessels. The 
basic principle of the RVA is based on the fact that RBCs within the retinal vessels absorb light at a 
maximum wavelength of 400–620 nm, whereas the background and surrounding fundus mostly reﬂects it. 
The differences between the brightness proﬁle of the RBC column within the vessel compared with that 
of the surrounding fundus are then used for further analysis. To achieve an optimum contrast for vessel 
visualization, a green ﬁlter is inserted into the illumination pathway of the fundus camera. Thus, the RVA 
therefore measures mainly the width of the RBC column within selected vessels 
117, 123
  
This technique however is complicated due to shadowing of structures and reflections from vessel 
surfaces. The RVA measures change in diameter in relative units, but is incapable of quantifying blood 
velocity or flow. 
1.4.2 Fluorescein Angiography  
Fluorescein angiograms have been used to measure MCT and AVP with the use of fluorescein dye 
injected intravenously through a retinal segment, assuming that the segment being investigated has a 
single inflow (feeding artery) and single outflow (draining vein) 
117
. Dilution curves are used to determine 
MCT 
124-126
. Several complications related to the properties of the dye, mode of its injection, method of 
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recording dilution curves, etc. make it difficult and imprecise to apply this technique to the eye; especially 
in the case of retinal vascular pathologies. MCT in this scenario is therefore considered only an estimation 
of true MCT 
118
. Fluorescence intensity emitted by the dye is measured and recorded when the fundus is 
illuminated with blue light which excites the fluorescein spectrum photographically or by video
117
. Other 
parameters such as mean velocity of the dye (MVD) in a retinal artery and AVP have been derived from 
the time course of the fluorescein intensity using scanning laser ophthalmoscopy 
127
. AVP strongly favors 
the measurement of passage times of the dye through the shortest segment between an arteriole and a 
venule close to the papilla 
118
. Additional limitations of this method to those previously mentioned include 
the assumptions that an arteriole is completely drained by a corresponding vein, the sum of vessel 
diameters is directly related to blood volume, no leakage of fluorescein occurs during measurements 
128
, 
the generally invasive nature of the procedure and anaphylactic reactions in response to the fluorescein 
chemical used. 
1.4.3 Blue Field Entoptic Technique  
The velocity, number and pulsatility of leukocytes in the macular of the retina can be determined using 
the Blue Field Entoptic Technique. The blue-field entoptic phenomena or “flying corpuscles” can be 
perceived using a deep-blue field of light with a narrow spectrum centered at a 430nm wavelength. This 
visual perception originates from within the terminal arterioles and capillaries in the inner retina 
surrounding the foveal avascular zone but can only be perceived when illuminated in a specific manner. 
The moving RBCs are seen in an area of 10-15 degrees of arc radius centered at the fovea 
129
. Participants 
are asked to make comparisons between a standard of moving computerized motion of leukocytes (at a 
known velocity) with their observations of movement of corpuscles 
117
. Measurements are therefore 
subjectively made based on the participant’s observation of the phenomena and highly dependent on the 
participant’s visual abilities requiring a visual acuity better than 20/50 for a reliable measurement 130. The 
objective scanning laser ophthalmoscope-adaptive optics imaging technique has been used to confirm 
measurements obtained with the blue-field technique 
131
. Limitations of this technique lie in its poor 
 
 
20 
 
reproducibility of results, subjectivity, individual variation and need for participants to have good visual 
acuity. 
1.4.4 Laser Speckle Technique  
The speckle effect is an interference pattern phenomenon that makes use of laser light sources or other 
coherent light sources 
132
. A speckle pattern is produced when there is a scattering of light upon 
illumination of the fundus. The pattern varies significantly dependent on the vascular blood flow velocity 
within the retinal vessels 
133
. The speckle patterns produces images with low contrast and blur when there 
is blood flow; the blur increasing with increased blood velocity and exposure time of the photo. In areas 
of no flow however, the image remains in high contrast with minimal blurring 
134
. This method provides 
an immediate overall map of blood velocities, as compared to other techniques such as Doppler 
velocimetry which gives measurements only at one point in time 
134
. Limitations of only providing semi 
quantitative estimations (non-absolute) of retinal microcirculation and the inability to follow time course 
changes however exist with this technique 
134, 135
. 
1.4.5 Laser Doppler Velocimetry  
1.4.5.1 Doppler Shift Theory 
The frequency,  of a beam of laser light scattered by a moving red blood cell (RBC) (moving at a speed 
; shifts by an amount  from the frequency of the incident light ( or from the frequency of 
reflected light from a stationary neighbouring object.  
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Figure 1.4.0: Diagrammatic representation of the Doppler shift effect. The frequency, f i of an incident wave of light 
changes by Δfma when reflected from a moving RBC.  
This theory is utilized in laser Doppler velocimetry (LDV). Here, scattered light reflected from moving 
RBCs in a blood vessel is spread out to form a spectrum called the Doppler Shift Power Spectrum (DSPS) 
136
 which contains both the original (f1, scattering from the vessel wall) and shifted frequency (f, 
scattering from moving RBCs) with a difference in frequencies, Δf. The direction of light waves is 
incorporated with angle α being the angle between the direction vector of Vmax and the reflected light 
wave and β, the angle  between the incident beam and resultant direction vector of Vmax   
137.  Δf is related 
to the velocity of RBCs by the equation: 
…………………………..6 
Where, V= velocity and λ is the wavelength of the incident light. 
1.4.5.2 Bidirectional Laser Doppler Velocimetry (BLDV) 
BLDV allows the quantification of absolute blood velocity in major retinal vessels with the use of a single 
laser and two laser photodetectors scattered by RBCs, with the application of the Doppler shift principle. 
RBF (µl/min) is calculated from the measurement of vessel diameter and of centreline blood velocity, 
Vmax. Using bi-directional laser Doppler velocimetry, the measurement of Vmax is independent of the angle 
of incident light 
137
 since the use of the two photodetectors separated by a known angle of separation 
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Incident 
beam, f 
α1 
results in frequency shift in two directions (K1 and K2, with frequencies fs
1 
and fs
2
 respectively) (Figure 
1.2) 
115
. The difference in frequency shift between the two photodetectors can be used to calculate 
absolute velocity irrespective of the angle, α according to the equation: 
………………………………8 
where,   ………………………………….9 
α1 and α2 are the associated angles to the frequencies of the original wave, f i and the scattered wave, 
(fi+Δfmax)  respectively. Δα is the angle between fs
1
 andfs
2
 (α1 - α2) and β is the angle between direction of 
the velocity and the incident beam. 
 
 
 
     
 
Figure 1.5 Doppler method of measuring blood flow (f=non shifted light ray, fi=shifted ray) 
With Vmax, the known angle of separation between the two laser lights (Δα) (which is used to determine 
the frequency shift in the two directions - fs
1
 and fs
2) and angle β (angle between the vessel plane at the 
measurement site and the direction of the velocity), RBF can be calculated with the knowledge of 
diameter, D, as well as velocity. Diameter is calculated using a green laser which is orientated 
Δα 
K1   fs
2 
β 
V
m
ax
 
 
 
K1    fs
1 
α2 
 
 
 
 
 
 
 
23 
 
perpendicular to the vessel wall and a densitometry methodology is then utilised to determine vessel 
diameter. (Figure 1.1) 
115, 138
. 
Total retinal blood flow (TRBF) ranges from about 40.8 to 52.9 µl/min in humans using BLDV 
115, 139
. 
RBF measurements from BLDV are larger in the temporal human retina than in the nasal region; this is 
believed to be due to the larger size (20-25%) and higher metabolic rate in the temporal retina. However, 
there appears to be no difference between RBF values in the superior and inferior hemispheres of the 
retina 
139-142
 
1.4.6 Color Doppler Imaging (CDI)  
Ultrasonography is utilized in the technique of CDI. CDI is used to image vessels behind the eyeball and 
acquire blood flow information by simultaneously combining B-scans of tissue structure, color-coded 
representation of blood flow and pulse-Doppler measurements of blood velocities 
143
. The color-coding 
varies in proportion to the velocity, with red-to-white for motion toward the probe and blue-to-white for 
motion away from the probe. CDI systems are unique because they use a single, multifunction probe to 
perform all functions. Parameters of blood flow that can be measured with CDI are peak-systolic velocity 
(PSV), the end-diastolic velocity (EDV), and the resistivity index 
50
. 
……………………….7 
Changes in hemodynamics have been shown with the use of CDI in a variety of ocular disease conditions 
such as retinal artery and vein occlusions, and glaucoma. It has also been used to detect vascularization of 
orbital and ocular tumors 
143
. CDI cannot be used to measure the diameter, and as such RBF cannot be 
quantified. Additionally, if excessive pressure is applied to the eyelid, this can lead to significant changes 
in intraocular pressure and thus, perfusion pressure and blood flow. Acquiring hemodynamic parameters 
has also been shown to be very subjective which may lead to measures that are not reproducible. There 
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appears to exist a learning effect curve with the use of CDI and thus operator experience becomes an 
essential factor 
50
.  
1.4.7 Doppler Fourier Domain Optical Coherence Tomography (FD-OCT) 
The RTVue Doppler FD-OCT (Optovue Inc., Freemont, CA) used in this study contains a 
superluminescent diode with a center wavelength of 841nm and a bandwidth of 49nm. The axial 
resolution is 5.6 μm in tissue and the transverse resolution is 20 μm since it is limited by optical 
properties of the eye. The technique utilizes a custom spectrometer, consisting of 1024-pixel high speed 
line-scan camera. 
In addition to obtaining morphological images, the FD-OCT can detect a Doppler shift of reflected light 
from RBCs which provides information about blood flow 
144, 145
. The differences in phase between 
sequential axial scans at each pixel are calculated to determine the Doppler shift. The Doppler shift is 
proportional to the velocity component parallel to the axis of the probing beam and introduces a phase 
shift in the spectral interference pattern that is captured by the line camera 
139
. The quantification of 
TRBF requires the knowledge of the incident angle between the OCT light beam and the resultant 
direction of movement in a given blood vessel, which cannot be acquired from a single OCT cross-
sectional scan. 3-D imaging of the vessel using more than one cross-sectional scan is required to 
determine the incident angle. This can be acquired with the Doppler Circular Scan Pattern (DCSP) of the 
RTVue Doppler FD-OCT which makes measurement of TRBF several times within a cardiac cycle (4 
times per second) 
146
. The DCSP consist of two concentric circles of 3.4 and 3.75mm diameters 
respectively which transect all retinal vessels entering and exiting the ONH in two locations. In a single 
acquisition, a total of six dual circular scan frames are obtained and averaged for each ring; with 5 to 6 
repeated measurements to ensure high quality scans. The Doppler angle is estimated from among other 
things the difference in vessel center depth between the two concentric rings in a single scan. This 
Doppler angle, together with the measured Doppler shift is used to calculate blood velocity, which when 
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combined with the vessel diameter volumetric flow can be derived. The methodology used in this study to 
derive retinal blood flow is a semi-automated software algorithm; Doppler Optical Coherence of Retinal 
Circulation (DOCTORC) 
147
. The sum of the flows from all branch venules at one time is computed as 
TRBF 
139
. 
 
 
1.4.8 Laser Doppler Flowmeter (LDF) 
LDF can be used to measure BF in the ONH using two main methods; dynamic and scanning 
118, 148
. The 
dynamic method occurs when the light scattered by a tissue when a laser beam of light is focused on it 
forms a DSPS due to RBCs in motion. Blood flow is then calculated as, 
  11 
Where, Velocity (Hertz) and Volume are the mean speed of the RBCs moving in the sampling volume 
and the number of moving RBCs respectively. K, is a constant of proportionality. In the scanning mode 
on the other hand, a laser beam is used across a two-dimensional area of the fundus providing an image of 
the RBC flow in the capillaries of the optic disk and peri-papillary retina, as well as a perfused image of 
the neuroretinal rim of the ONH 
149
. 
Figure 1.6: En face view of 3D OCT image showing DCSP with two concentric rings of radii 3.75 and 3.40mm. 
The retinal vessels are labelled from 1 to 15. The red and blue colour represents software identified vessel type as 
blood flowing away from the ON 
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1.5 Partial Pressures of Oxygen, Nitrogen and Carbon Dioxide (PO2, PN2 and PCO2) 
The partial pressure of a gas (PP) in a mixture of other gases is the pressure exerted by that gas alone and 
is directly proportional to the rate of diffusion of the gas. The pressure of the gas in humans acts initially 
on the surface of the respiratory passages and alveoli and is directly proportional to the concentration of 
the gas molecules. Inspired air is made up of three main gases, approximately; 21% oxygen (O2), ~0.03% 
carbon dioxide (CO2) and 79% nitrogen (N2). The total pressure of inspired air at sea level is about 
760mmHg, which is termed the ‘atmospheric pressure’.  PO2, PN2, and PCO2 is thus 160mmHg (21% of 
760mmHg), 600mmHg (79% of 760mmHg) and 22.8mmHg (0.03% of 760mmHg) respectively. At the 
level of the alveolus, PO2 is 100mmHg. This measure is termed ‘normoxia’ or ‘baseline’. 
Gases dissolved in tissues of the body move randomly and have kinetic energy; therefore, they exert a 
partial pressure just as they do in the gas state when it comes into contact with a surface such as a cell 
membrane. Besides the concentration, the solubility coefficient of the gas also determines its partial 
pressure. According to Henry’s law some molecules are more attracted to water molecules than others e.g. 
CO2, this makes them easily dissolved without building up excess partial pressure within a solution and 
vice versa in the case of molecules that are repelled by water molecules 
20
. This is according to the 
equation: 
…………………..12 
When partial pressure is expressed in atmospheres (1 atmosphere pressure = 760 mmHg) and 
concentration is expressed in volume of gas dissolved in each volume of water, the solubility coefficients 
for the three major components of inspired air are 0.024, 0.57 and 0.012 for oxygen, carbon dioxide and 
nitrogen 
20
. 
The change in PaO2 and PaCO2 is reflected by the change of PETO2 and PETO2 respectively 
150
. PETO2 is the 
maximum concentration of O2 present at the end of an exhaled breath; that is, ‘the tension of a gas in a 
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mixture of gases from all ventilated alveoli, including alveolar dead space, i.e. at functional residual 
capacity’ 151.  
1.5.1 Diffusion of Gases Between the Gas and the Dissolved Phase  
The gas present in the alveolar respiratory gas mixture is forced by its partial pressure into blood solutions 
of the alveolar capillaries. Dissolved gas molecules are also capable of diffusing out of the blood. The net 
diffusion of the gas is determined by the difference between the two partial pressures; this is usually 
higher in the gas phase of the alveoli for oxygen, thus resulting in oxygen molecules diffusing into the 
blood more than in the other direction. 
1.6 Oxygen Loading & Transport 
The bulk (~98%) of oxygen is carried in the body to the tissues combined with hemoglobin (Hb), while 
the remaining 2% is dissolved in blood plasma after diffusing from the alveoli into the pulmonary blood.  
Hb consists of a protein (globin) molecule attached to four iron-porphyrin (heme) groups. Each heme 
group is able to carry only a single molecule of O2; suggesting that one Hb molecule can bind a total of 4 
molecules of oxygen. Oxygen binds loosely and reversibly to the heme group; the higher the PO2 the 
more affinity it has for Hb. This facilitates the loading of oxygen in the lungs and the release of oxygen to 
the tissues: 
…………….13 
Oxygen saturation (SO2) is the measure of the percent amount of Hb bound to oxygen: 
……………………14 
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1.6.1 Oxygen-Hemoglobin Dissociation Curve (OHDC) 
The relationship between PO2 and SO2 is graphically illustrated in the OHDC (Fig 4). Oxygen loading in 
the lungs and oxygen release to the tissues is facilitated by the sigmoid shape of the OHDC curve. 
Generally, as PO2 increases there is a steady increase in the SO2. The SO2 of systemic arterial blood is 
about 97% on average and 57% in the venous blood 
20
. 
  
 
 
 
 
Figure 1.7 Oxygen-Hemoglobin Dissociation Curve. 
1.6.2 Arteriovenous Oxygen Difference  
The extent to which oxygen is consumed and subsequently removed from the blood as it passes through 
the body is characterized by the arteriovenous oxygen difference (AVD). AVD is the difference between 
the oxygen content of arterial blood and that of venous blood. It may be expressed as millilitres of oxygen 
per 100mL of blood 
152
. 
Oxygen Delivery 
Oxygen delivery by the retinal blood (FO2), is the sum total of oxygen delivered to the retina from the 
retinal circulation. FO2 is the product of the AVD, the RBF and the oxygen capacity of arterial blood, 
0.201 µl/min 
153, 154
. 
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……………….. 15 
1.7 Retinal Oximetry 
Oximetry is the quantification of the amount of oxygen saturated within the blood of the vessels in the 
body tissues mostly with the use of spectral analysis techniques. In retinal oximetry, the different 
absorbance spectra of oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) is quantified using light of 
specific wavelengths (oxygen sensitive and oxygen insensitive wavelengths) from a narrow band light 
source. The absorption characteristics of HbO2 and Hb can be expressed by the extinction coefficients of 
Hb (Fig 1.5) 
155
. Light penetrates to different depths of the retina depending on the wavelength of 
illuminating light and is generally more easily transmitted through human tissue at wavelengths between 
660nm and 940nm, than it is at wavelengths below 660nm where blood significantly absorbs the light and 
transmits little (Fig. 1.5). 530-580nm light illuminates the retinal background and retinal vessels while 
wavelengths above 600nm penetrate the retinal vessels and background to the level of the choroid at 
640nm 
156
. Scattering of light occurs due to changes in the refractive index between RBCs and the blood 
plasma in which they are contained. 
 
Figure 1.8 Graph displaying the absorption spectra of Hb and HbO2 
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Reprinted by permission from Macmillan Publishers Ltd: [Eye] 
157
, copyright 2011 
1.7.1 Principle of Retinal Oximetry & The Beer-Lambert Law 
Assuming that blood is comprised entirely of HbO2 and Hb, SO2 can be defined as: 
…………………..16 
Where, CHbO2 and CHb are the molar concentrations of oxygenated and deoxygenated haemoglobin 
respectively. 
The Beer-Lambert law represents; the basis of spectral analysis and it explains that “the  concentration of 
an absorbing substance in solution can be determined from the intensity of light transmitted through that 
solution, given the intensity and wavelength of incident light, the transmission path length, and the 
characteristic absorbance of that substance at a specific wavelength (extinction coefficient)” 158. The 
attenuation of light by a sample of blood can be described as the linear sum of the attenuation of each 
component:  
…………………..16 
Where, ɛ ai is the extinction coefficient due to absorption at wavelength λ, c is the concentration of the 
retinal chromophores (Hb and HbO2), d is the path length travelled by the photon through the sample, and 
i denotes the individual chemical species in which the light travels.  Measuring the attenuation at several 
wavelengths equal to the number of chromophores is sufficient to calculate the concentration of each 
particular chromophore. Difficulties arise in quantifying, d due to the high scattering and absorption 
characteristics of light occurring in the retina. To overcome this, multiple optical-path parameter η, and 
losses resulting from scattering (S), are incorporated into the Beer-Lambert law (eqn. 17). Measuring the 
attenuation at numerous wavelengths is therefore necessary to estimate the concentration of 
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chromophores. In blood oximetry, two wavelengths are sufficient to calculate SO2 when the scattering is 
assumed to be independent of wavelength 
156
. 
……………………17 
1.8 Historical Approaches of Measuring Retinal Oxygen Saturation 
The determination of retinal oxygen saturation has proven to be very challenging 
50, 136, 137
. Over the years, 
several approaches have been devised for retinal oximetry such as spectral image analysis techniques with 
a fundus camera, and more recently the use of ultrahigh-resolution OCT (UHR-OCT). However, there 
still remains the lack of a gold standard methodology for the assessment of retinal SO2 in humans. 
Regardless of the technique employed, each principle of retinal oximetry is based on the differences in the 
absorption spectra of oxy and deoxyhemoglobin. Typically, the data output is in the form of a spectral 
cube (two spatial dimensions and wavelength as the third dimension) 
13, 156, 159
. Due to spectral properties 
and the spatial distribution of retinal chromophores, spectral retinal images show variation in contrast 
with different wavelengths due to the different amounts of light absorption of oxy and deoxyhemoglobin 
at each wavelength.  Four major methods of measuring retinal SO2 have been discussed below; 
hyperspectral imaging fundus reflectance, Hickam’s photographic two wavelength method and 
photoelectric oximetry with three wavelengths from Delori and co-workers (1988). However, several 
other methods exist such as the imaging ophthalmospectrometer 
160
 , the scanning laser eye oximeter 
161
, 
the computed tomographic imaging spectrometer 
162
, the fourier transform spectral retinal imager 
163
 
amongst others. 
1.8.1 Digital Multispectral and Hyperspectral Imaging of the Retina 
Beach & co-workers (1999) developed a two-wavelength spectral imaging system which contained a 
beam splitter that  enables the simultaneous acquisition of two retinal images which are then filtered using 
narrow bandpass interference filters centered at 569nm and 600nm with 4.5mm FWHM. Optical density 
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ratios (ODRs) were calculated and used to determine SO2 using the linear relationship between ODRs and 
SO2  
9, 164, 165
. The influence of fundus pigmentation was factored into the calculation of ODRs. Mean 
retinal venous oxygen saturation was  in normoxia and  during hyperoxia (100% 
inspired oxygen). This system was developed to measure SO2 in the retinal vasculature of diabetic 
subjects. 
More recently, Khoobehi and co-workers (2004). developed a hyperspectral imaging system to evaluate 
relative SO2 in the retinal vessels and ONH tissues consisting of a fundus camera with an attached prism 
grating prism spectrograph coupled to a CCD digital camera 
166
. A sequence of line scans across the optic 
disc provided spectral reflectance in the wavelength range 410-950nm. This one-dimensional information 
of spectral reflectance was converted into a three-dimensional data cube by moving the imaging system to 
obtain the second spatial dimension (Fig 1.5).  
SO2 maps were subsequently used to determine changes in SO2 changes in retinal vessels and ONH 
tissues with the use of a spectral profile analysis of Hb at high and low oxygenation between 530nm and 
584nm. Further improvements to this method include the inclusion of a correction factor for blood 
volume and variation in illumination in vessels overlying ONH and tissues 
167
. Limitations of this method 
include motion artifacts and the technique is poor and therefore limited to use in animals.  
Simultaneous retinal images at four wavelengths have been made possible by Stefansson 
168
, an 
adaptation of the Beach and co-workers (1999) two-wavelength method 
9
. A beam splitter allowed the 
replication of the original retinal image into four retinal images filtered at wavelengths of 542, 558, 586, 
and 605nm. Algorithms for registration and vessel detection were used to align images and detect vessels 
which were then subsequently used to calculate ODRs. ODRs were calculated using 586nm and 605nm 
retinal images based on the Beach and co-workers. technique 
9
. The mean arteriolar retinal SO2 at 
normoxia was 96±9% and 55±14% for mean venular oxygen saturation. In a state of hyperoxia, these 
amounts increased to 101±8% and 78±15%. The limitations of this technique are its failure of addressing 
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the influence of confounding factors such as light scattering, fundus pigmentation and vessel diameter. 
This raises questions about validity of the method. 
1.8.2 Fundus Reflectance Oximetry 
One of the first studies that looked at changes in retinal SO2 on reflectance from the fundus under 
monochromatic illuminations was conducted by Gloster et a. in 1967 
169
. These experiments focussed on 
reflectance of different colours from the choroid when the concentration and oxygenation of blood was 
altered. These changes to blood resulted in a change in colour to red and cyan. Incident light was filtered 
by three filters. The limitations of these experiments were that they were qualitative in nature and could 
not quantify retinal SO2 measurements. 
1.8.3 Hickam Photographic Two Wavelength Technique  
In this technique of estimating SO2 in retinal veins of humans, two-wavelength imagers (centered at 640 
and 800nm, and 640 and 505nm) are utilized to illuminate the fundus 
12
. Absorption profiles acquired 
with a microdensitometer are produced with retinal images recorded on photographic film. ODRs were 
calculated from optical density measurements for all the wavelengths. A linear relationship between 
ODRs and retinal SO2 was established with the use of isobestic (oxygen insensitive) wavelengths. The 
average retinal venous oxygen saturation for the 640,505nm pair was calculated as 58±10% and 60±16%. 
Limitations of this technique included the influence of vessel diameter on retinal SO2 estimation. Smaller 
vessels were not consistently detected in the reflectance profiles produced. 
1.8.4 Photoelectric Oximeter with Three Wavelengths  
Retinal SO2 was determined in this method by utilizing a three-wavelength (558nm, 569nm and 586 nm at 
7-8 FWHM) photoelectric oximeter to determine retinal SO2 
170
. A fundus camera was employed with 
three interference filters, a photomultiplier (to enhance reflections from the fundus) and a photocathode. 
Light reflected from the fundus was filtered into three wavelengths centered at 558nm, 569nm and 586 
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nm (7-8 FWHM). This technique allows the scanning of selected retinal vessels using a slit because a 
small area of the fundus was illuminated at a time 
1.8.5 Image Replicating Imaging Spectrometer (IRIS) Hyperspectral Retinal Camera (Photon 
etc. Inc. Montreal) 
This technique allows for two-dimensional spectral and spatial information to be recorded in a single 
exposure 
171
. The device is a spectral demultiplexer that allows for replication of original images in 
multiple spectral bands onto a single detector array by employing polarizing interferometry and 
Wollaston prism polarizing beam splitters 
156
. The device has a built in prototype mydriatic fundus 
camera with a tunable laser source (TLS) allowing for observance of the fundus at wavelengths ranging 
from 420 to 1,000nm with safe and comfortable illuminations. The TLS is based on the Bragg grating 
filtering technology allowing for rapid and accurate (<1nm) wavelength selection from the 
supercontinuum source. For high definition imaging, it contains a sensitive CCD camera and spectral 
reproducibility in time is assured with a built in calibration system 
172
. Two-dimensional images of the 
retina are recorded and registered to produce a spectral cube while assuring patient comfort and simplified 
calibration procedures. Other spectral cameras make use of a snapshot flash system that changes the 
physiology of the fundus and subsequently affects derivation of accurate retinal SO2 
173
. The IRIS HRC 
however does not use a flash, thus the physiology of the retina is maintained due to its smaller bandwidth 
of 2nm (FWHM). The IRIS HRC has longer acquisition times compared to most other snapshot methods 
(80ms exposure time, 0.5s per wavelength) making it susceptible to movement artefacts and light 
intensity changes. This method is utilized in this study. Image cubes acquired with the HRC contain 
fundus reflectance profiles of nine wavelengths; 451, 540, 548, 558, 569, 586, 600, 605 and 610 for each 
of the two baseline phases per participant. Image cubes centered on the optic disk were acquired with the 
PHySpec V1.17.0 (Photon etc. Inc. Montreal, Canada) custom designed software.  
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1.9 Summary 
The retina, unlike the choroid is autoregulated 
55
. The arterioles of the retina are resistance vessels that are 
believed to be primarily involved in perfusion processes in the retina, and the regulation of blood flow to 
the capillaries 
14
, where nutrients and gases are exchanged with the tissues 
14-16
. There are major structural 
and functional differences between the choroidal and retinal vascular systems 
21, 22
. 
Ocular blood flow follows Poiseuille’s Law, and is affected by a number of local and systemic factors 
such as oxygen and carbon dioxide tension, circulating hormones, endothelial derived factors and the 
ANS. NO and Endothelin-1 are believed to be the most important endothelial derived relaxing and 
constricting factors respectively 
22
. Over the years, several noninvasive methods of quantifying ocular 
hemodynamics have developed and have then been applied to determine the magnitude of response to 
external biologic stimuli. The RTVue Doppler FD-OCT (Optovue Inc. Freemont, CA) is unique in that it 
provides the capability of quantifying TRBF non-invasively through the detection of Doppler shift of 
reflected light from RBCs with the DCSP and semi-automated DOCTORC software.  
Like RBF, several approaches have been devised for the measurement of retinal blood SO2 in the 
scientific literature 
3, 64, 65
. These methods were spearheaded by Hickam and co-workers in the 1960s 
12
, 
but is yet to be mastered as a technique that is reliable and useful clinically. The IRIS
TM
 Hyperspectral 
imaging device (Photon etc. Inc. Montreal, Canada) (IRIS HSRC) makes possible the measurement of 
retinal SO2 through the localization of structures in the retina using their specific spectral signatures 
through non-invasive means. At specific wavelengths in the visible spectrum (e.g. 585 nm) there is strong 
absorption by the hemoglobin, which enhances the contrast of blood vessels. Oxygenated 
(oxyhemoglobin) and deoxygenated hemoglobin (deoxyhemoglobin) show different absorption spectra, 
thus making it possible to distinguish between arterioles (A) and venules (V) 
174
. This process is known as 
retinal oximetry and is based on spectral analysis techniques according to the Beer-Lambert Law which 
makes use of specific oxygen sensitive and insensitive wavelengths from light-emitting diodes (LEDs). 
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The IRIS HSRC allows for two dimensional spectral and spatial information to be recorded in a single 
exposure 
171
. Unlike other oximetry snapshot systems, the IRIS HSRC does not make use of a flash, thus 
ensuring equi-luminance due to its smaller bandwidth of 2nm (FWHM). Retinal oximetry is a relatively 
novel technique which is still at 1
st
 base in terms of practical development. 
Several major ocular diseases such as retinopathy of prematurity (ROP), retinitis pigmentosa, age-related 
macular degeneration (ARMD), diabetic retinopathy (DR) and glaucoma 
175, 176
 have been shown to have 
components of reduced OPP, blood flow deficits and subsequent hypoxia. Therefore, the essential role of 
blood flow and oxygen in maintaining ocular health cannot be underestimated. RBF varies inversely, 
while SO2 varies directly with the partial pressure of arterial oxygen (PaO2) to maintain retinal 
oxygenation at a relatively constant level 
177
. Studies that provide data on TRBF and retinal SO2 with 
stepwise changes in PaO2 in conditions of hypoxia and hyperoxia would provide significant knowledge 
into understanding blood flow physiology and possibly the mechanism of various major ocular disease 
processes and their diagnosis.  Additionally, it would bring us a step closer to providing a gold standard 
for routinely measuring oxygen and blood flow changes in human ocular disease conditions. 
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2 Rationale, Hypotheses and Aims 
        ide a greater insight into the pathophysiology of ocular disease processes and may aid diagnosis and 
management. FD-OCT provides the means for quantification and detection of early retinal morphometric 
changes associated with major retinal and systemic diseases. It also allows for the assessment                                                             
of the effectiveness of new treatment regimens through the provision of non-invasive, 3-dimensional, 
high-resolution, histological details of the ONH and the retina of the living human eye 
178
. The potential 
of FD-OCT technology to provide information on the vascular function of the retina and ONH, however, 
has yet to be fully exploited. Using the new and unique methodology of the Doppler FD-OCT it is 
possible to measure TRBF with the use of the Double Circular Scan Protocol (DCSP) which estimates the 
Doppler angle (incident angle between the OCT light beam and the blood vessel) unlike most other blood 
flow devices. Doppler FD-OCT however has yet to be fully tested and validated.  
This study is further unique in its use of the combination of a computer-controlled gas sequencer that 
allows the implementation of precise combinations of oxygen and CO2 concentrations as provocative 
stimuli that provoke blood flow change, and the quantification of retinal blood flow techniques which 
deliver a much improved signal-to-noise ratio compared to previous methods; this in turn provides 
reliable and highly reproducible data. The systemic arterial gas composition was manipulated using a 
sequential rebreathing circuit (HiOx-80, VIASYS Healthcare Inc.) connected to an automated gas blender 
(Respiract
TM
, Thornhill Research Inc., Toronto, Canada) to provoke hyperoxic and hypoxic conditions 
179
. 
This allowed the examination of the effect of the provocation on vascular beds in the retina.  
Hyper-spectral retinal imaging offers the potential to non-invasively quantify retinal blood SO2 
disturbances in the retina prior to the development of clinically visible disease and potentially prior to the 
development of any morphometric change 
180
. This spectral imaging technique can be used to detect and 
quantify various metabolic “signatures”, or molecular spectral absorbance profiles, in the retinal tissue 180. 
The hyperspectral retinal camera (HRC) prototype used in this study is unique in that it does not employ a 
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flash, like other snapshot hyperspectral techniques. The use of a flash bleaches the photopigments and 
subsequently alters the reflective properties of the retina. Research in the area of spectral imaging of the 
retina, and more specifically, quantifying retinal ODRs , remains in the early stages despite methods being 
established as far back as the 60’s. The HRC prototype device has the potential of bringing revolutionary 
change in this field; however, it requires further studies for validation of the technique.  
RBF and retinal SO2 are closely related hemodynamic measures, in that, the bulk of oxygen produced by 
the human body is carried attached to Hb molecules of the RBC’s. RBF is very commonly used as a 
substitute measure for tissue oxygenation and metabolism, however, at this time we cannot assume that 
retinal blood SO2 can be directly quantified routinely with current blood flow measuring technologies 
175, 
181
.  Oxygen utilisation is a function of blood SO2 and blood flow. Optical density ratios of blood allow us 
to potentially measure retinal SO2 through the relationship between ODR and SO2. TRBF varies inversely 
with PETO2 to keep retinal SO2 fairly constant 
3, 3, 177
. Normative data of TRBF and especially retinal SO2 
for novel devices such as the Doppler FD-OCT and HRC are required for validation needs. This is the 
first study to the best of our knowledge reporting measurements of retinal blood SO2 and TRBF with the 
Doppler FD-OCT and HRC with stepwise changes in PETO2 using the full range of retinal vascular 
reactivity on healthy participants. The results of this study will elucidate a more comprehensive 
understanding of retinal vascular physiology and provide further validation data for the Doppler FD-OCT 
device and the HRC.  
In turn, the work should lead to improved understanding of the vascular pathogenesis of ocular disease. 
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2.1 Hypotheses 
The hypothesis for Chapter 3 is that the 605/586 wavelength combination out of the three ODRs 
(600/569, 610/548 and 605/586) being considered, will show the least variation (range ± standard 
deviation) in arterioles and venules based on previous literature and pilot studies conducted in our lab. 
The 605/586 wavelength combination will provide the least variable ODR for estimating retinal blood 
SO2 in future studies with our prototype oximeter. 
In Chapter 4, the hypothesis is that TRBF will decrease as retinal blood SO2 is increased in healthy 
participants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
2.2 Aims 
The aim of the study in Chapter 3 is to determine the least variable (range ± standard deviation) 
wavelength combination (610/548, 600/569 and 605/586) and subsequent ODR with the prototype HRC 
device. 
In Chapter 4, the specific aims of the study are to: 
1. Quantify retinal blood SO2 (in arterioles and venules) with the chosen wavelength combination in 
healthy participants.  
2. Investigate the relationship between retinal SO2 and retinal blood flow in healthy participants. 
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3 Optical Density Ratio (ODR) Variability with a Novel Hyperspectral Retinal Camera (Photon 
etc. Inc. Montreal) 
3.1 Introduction 
Oximetry methods have been used to determine the SO2 of blood perfusing human tissues for several 
decades 
12, 17, 18, 30, 154, 182, 183
. In healthy individuals, the spectroscopic techniques for determining retinal 
blood SO2 have been shown to produce values that are reliable, stable 
30, 168
 and are able to show change in 
retinal vessel SO2 in numerous eye diseases such as retinal vein occlusions 
184
, diabetic retinopathy 
185-187
 
and glaucoma 
10, 188
. Retinal oximetry has also demonstrated systemic hypoxia in Eisenmenger syndrome 
189
. 
Central to retinal oximetry is the use of optical density, i.e.  and subsequent ODRs of oxygen 
sensitive and insensitive (isobestic) wavelengths, made possible by the different absorbance spectra of 
HbO2 and HbO of light reflected from the surface of the retina. Retinal oximetry is affected by several 
extraneous factors such as light scattering, diffusion of light resulting from the choroid, lack of uniformity 
in the background pigment with wavelength, corneal reflections 
190
, retinal nerve fiber bundle induced 
reflectance variations and the close proximity of vessels, eye movements, pupil edge light scattering and 
pigment clumping.  
Spectral analysis techniques such as retinal oximetry require the choice of specific wavelengths, a 
critically important specification for reliable and optimal measurements of optical density 
170, 191, 192
. 
Previous studies on retinal oximetry by photographic means have made use of two wavelengths; one 
oxygen sensitive wavelength (large difference in the extinction coefficients) and one isobestic wavelength 
(oxygen insensitive wavelength) to derive the ODR (fig 1.5) 
30
.  
The spectral content of reflected light depends on not only the retinal blood SO2, but also on the blood 
concentration, layer thickness and scattering of light inside the blood vessel lumen, including the number 
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of passes through the vessel (i.e. 1 or 2).  There is strong absorption by Hb wavelengths around, for 
example, 585 nm (Fig 1.5), which enhances the contrast of blood vessels. The change in contrast and 
intensity at two wavelengths chosen enables the derivation of SO2; that is, between oxygenated and non-
oxygenated blood 
193
. 
Various studies have made use of different wavelength combinations. Hickam and co-workers (1963) 
employed modified fundus cameras and used two different wavelength combinations in the first retinal 
oximetry experiments. Broadband (>100nm FWHM) Wratten filters at 800 and 640nm in a red-infrared 
instrument and in later experiments wavelengths of 640 and 510nm were employed by a red-green 
instrument using interference filters (10nm FWHM) 
12
. Manual analysis of exposed films was used to 
measure the optical densities of vessels 
161
. A similar device reported by Cohen and Laing employed a 
blue-green combination centered at 470 and 515nm, with interference filters (20nm FWHM) 
194
. A 
retinal vessel oximeter was reported by Delori in 1988 that made use of three wavelengths; 558, 569, 
and 586nm. Tiedeman and co-workers (1998). also developed a retinal oximeter which illuminated 
filtered light (8nm FWHM) at 569 and 600nm. Images were acquired on a CCD camera with a high 
dynamic range 
195
. Retinal vessel oximeters making use of diode lasers at 670 and 803nm as a source of 
light was first reported by Smith and co-workers (1998) 
161
. More recently, the Oxymap T1 (Oxymap 
ehf., Reykjavik, Iceland) retinal oximeter by Geirsdottir and co-workers (2012) 
153
 based on the earlier 
approach of Beach (1999) 
9
 is able to simultaneously produce two fundus images with two different 
wavelengths (570 and 600nm; 5nm FWHM) of light at identical locations in the retina. This device 
consists of two digital cameras. Hardarson and co-workers (2006)
168
 using the same method of Beach 
znd co-workers (1999), used two retinal oximeters composed of a fundus camera coupled to a digital 
camera with a beam splitter in further experiments. A 586 and 605nm wavelength combination was 
used (5nm FWHM). In this study, a novel HRC with a prototype fundus camera, a tunable laser source 
based on the Bragg grating filtering technology and a high definition CCD camera with a bandwidth of 
2nm (FWHM) was used. Three wavelength combinations (ODRs) have been separately employed (600 
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and 569nm, 605 and 586nm, 610 and 548nm) for the analysis of retinal oximetry. Other spectral 
cameras make  use  of  a  snapshot  flash  system  that bleaches the photopigments and therefore alters 
reflectance characteristics of  the  fundus  due  to  uneven illuminations and subsequently affects 
derivation of accurate ODR readings 
172
. The HRC does not use a flash, thus avoiding major bleaching of 
the photopigment during image acquisition. 
Authors/Technical 
System 
Wavelength 
(nm) 
Calibration Arterial 
SO2 
Venous SO2 Other 
Hickam et al.
1,2,3 
Photographic 
640,800 Hypoxia  58% ± 10% 
 
 
 
Tiedeman et al.
4 
Digital 
640,505 
 
 
 
 
 
Hypoxia 
 
 
 
 
 
 
 
 
 
 
 
60% ± 16% 
 
 
 
 
Considered 
diameter and 
fundus 
pigmentation in 
calculations 
Hardarson et al.
5 
 
 
 
 
 
 
 
 
Beach et al.
6 
586, 605 
 
 
 
 
 
 
 
 
600,569 
Published 
arteriolar 
and venular 
SO2 
measures 
from 
previous 
works
** 
 
Hypoxia 
96%±9% 55% ± 14% 
 
 
 
 
 
 
 
 
55%±3.39% 
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Delori et al.
7 
Photoelectric 
586,569,558 Published 
extinction 
coefficients 
98% ± 8% 45% ± 7% Used scattering 
factor; considered 
hematocrit, 
diameter, and 
fundus 
pigmentation in 
calculation 
Schweitzer et al.
8 
Imaging spectroscopy 
510 to 586 Model 
function 
separating 
the effects 
of 
transmission 
and 
reflection 
92.2%±4.1% 57.9%±9.9% Multitude of 
wavelengths used 
to minimize error 
Smith et al.
9,10,11 
Multispectral confocal 
*SLO
 
 
Lompado et al.
12
 
 
 
Denninghoff et al.
13
  
488, 635, 
670, 830 
In vitro model  Triggered by 
electrocardiogram 
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Heaton et al.
14 
 
De Kock et al.
15 
Pulse 
660, 940 In vitro 
model 
97%   
Cohen and Laing
16 
Photographic 
470, 515 Rabbits    
*SLO – Scanning Laser Ophthalmoscope 
 
Table 3.1Wavelength Combinations Used by Various Investigators 
13, 190
 
There has not been any well-defined standard criterion reported for the determination of the best 
wavelength pairs for use in retinal oximetry. However, the commercial availability of sources of light that 
produce the desired wavelengths (red or near infrared) appears to be used as one of the selection criteria. 
Diode lasers are usually the light source of choice for use in retinal oximetry instruments 
161
. Fundus 
reflectance variation is predominantly from the retinal pigment epithelium because of high choroidal 
absorption 
170, 191
. Wavelengths more than 640nm, show non-uniformity of fundus background reflection 
with poor vessel detection due to poor contrast and the colour of the fundus becomes more spatially 
variable and additionally, transmittance is fairly low at wavelengths longer than ~920nm 
196
. At 
wavelengths lower than 520nm, the measured signals are generally too small and thus too noisy for 
further interpretation. There is also light scattering in the ocular media especially in vessel walls, low 
fundus reflectance and retinal exposure limits exist at wavelengths below 450nm 
170
. Retinal surface 
reflections are pronounced between 450 and 580nm especially in young individuals 
170, 191
.  Large surface 
reflections result in minimal to no contribution to reflectance from deeper layers leading to errors in 
retinal SO2 calculations 
13
. The extinction coefficients of Hb and HbO2 decrease drastically between 580 
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and 600nm 
155
 resulting in poor contrast images and subsequent difficulty in detecting retinal vessels 
170
. 
All things being considered, wavelengths from 450nm - 1000nm (inclusive) appear to be the most 
accepted and widely used range (within limits) of wavelengths for retinal oximetry 
161
. The choice of 
wavelength combinations for our studies was largely dependent on results from preliminary studies within 
the lab and elsewhere. 
Assumptions made in previous studies are that the contributions of numerous other Hb derivatives (e.g. 
methehemoglobin, carboxyhemoglobin, sulphehemoglobin) present in the blood are insignificant. This 
same assumption will hold in this study.  
The hypothesis for this study is that the 605 and 586nm wavelength combination will provide the most 
consistent ODR to estimate retinal SO2 in arterioles and venules in terms of least variation (range ± 
standard deviation). This hypothesis is based upon previous literature and prior pilot studies conducted 
within our lab with the prototype HRC device. Each wavelength combination will be assessed using 
healthy participants over a series of stepwise changes in values. 
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3.2 Materials and Methods 
3.2.1 Sample 
Ethical clearance was obtained from the University Health Network Research Ethics Board, Toronto and 
the University of Waterloo Office of Research Ethics prior to the commencement of the study. After 
explaining the study and its possible consequences to each study participant, informed consent was 
obtained according to the Declaration of Helsinki. The study sample was made up of ten healthy 
individuals (five males and five females) between the ages of 23 and 37, with an average age 28.3 years 
(SD 3.90) who were recruited from the School of Optometry and Vision Science, University of Waterloo 
and Department of Ophthalmology and Vision Sciences, University of Toronto. Of the 10 recruited, 1 was 
of Middle Eastern, 3 were Black/African, 2 were Asian, 2 were White and 2 were of Indian descent. The 
right eye of each participant was chosen for the study for convenience of use with the prototype HRC. 
Participants with distance refractive errors > 6.00 DS and/or 2.50 DC, any indication or history of 
chronic / serious eye disease (glaucoma, diabetes, or any ocular disease permanently affecting vision or 
requiring surgery) in self or first degree relative or systemic disease (endocrine disorders, 
hypercholesterolemia, etc.), stroke or chronic obstructive/restrictive lung disease such that the volunteer is 
unable to walk up 2 flights of stairs or on any medications with known vascular effects (antioxidants, 
blood pressure medication, etc.) were excluded from the study. In addition, participants who were unable 
to cope with the breathing protocol e.g. due to claustrophobia, those who were habitual smokers (or quit 
smoking within past 6 months) or those who showed non-compliance with prescribed anti-seizure 
medication or who demonstrated a resting arterial SO2 while breathing room air < 95 % were also 
excluded. Additionally, participants were asked to abstain from vitamin C, caffeine, red meat, chocolate, 
alcohol and exercise for at least 12 hours prior to the study visit.  
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3.2.2 Study Visits 
Participants attended a single visit scheduled between 9am and 11am for all participants. Retinal blood 
ODR measurements were taken with the HRC  
3.2.2.1 Novel Hyperspectral Retinal Camera  
This prototype device allows for two-dimensional spectral and spatial information to be recorded 
in a single exposure 
173
. The instrument comprises a custom-made mydriatic fundus camera with a 
tunable laser source (TLS) allowing for observance of the fundus at wavelengths ranging from 420 
to 1,000nm at safe and comfortable illumination levels without the need for flash illumination. The 
TLS is based on the Bragg grating filtering technology from Photon etc. which allows for rapid and 
accurate (<1nm) wavelength selection from the supercontinuum source from 400 to 1000nm with a 
bandwidth of 2.5nm (FWHM). For high definition imaging, it contains a sensitive CCD camera and 
spectral reproducibility in time is assured with a built in calibration system 
171
. The CCD sensor has a 
dynamic range of 14bits, and pixel scan rate and data rate of 12MHz/24MHz and 19.5 Mpixel/s, 
respectively. The spectral range of the sensor is 290nm to 1100nm. Two-dimensional images of the 
retina are recorded and registered to produce a spectral (i.e. third dimension is colour) cube while 
assuring patient comfort. The image capture time of the HRC is 80ms. A 2x2 binning mode was used 
with an effective pixel resolution of 696x520 pixels.  
 
3.2.2.2 Gas Delivery System (RespirActTM, Thornhill Research Inc., Toronto, Canada)  
The gas delivery system employed in the study was made up of a sequential re-breathing gas delivery 
circuit (Hi-Ox80, Viaya Healthcare, Yoruba Linda, CA). The circuit which was attached to participants 
via a facemask was made up of a commercial 3-valve oxygen delivery system with a rebreathing bag on 
the exhalation port.  Participants breathed previously exhaled gas from the rebreathing bag when the 
contents of the fresh gas reservoir were depleted. The circuit was in turn connected to an automated gas 
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flow controller (RespirAct
TM
, Thornhill Research Inc. Toronto, Canada) and blender that has been 
primarily developed and employed for the purposes of gas provocation by the Fisher laboratory at 
University of Toronto for over a decade. Similarly, Hudson laboratory have contributed to the 
development of the instrument from the beginning and have used it for over a decade.  The device enables 
the precise control of the partial end tidal pressures of oxygen (PETO2) and carbon dioxide (PETCO2). By 
modulating the inspired portion of oxygen and carbon dioxide, it is possible to accurately and repeatedly 
generate stable controlled and safe levels of hypoxia and hyperoxia. This technique uniquely targets exact 
pre-determined PETO2 levels and sustains them while maintaining isocapnia over the pre-determined phase 
duration, irrespective of the individuals’ respiratory rate. PETO2 and PETCO2 accurately measure PaO2 and 
PaCO2, respectively, when breathing using the RespirAct
TM
 sequential re-breathing gas delivery system 
197, 198
. The benefits of using this technique include the avoidance of under or overshooting the desired 
PETO2 and PETCO2, hence the consistency of data is improved. Also, safety improves since the risk of 
overshooting the target end tidal gases into dangerous levels are eliminated providing improved safety, 
sustained systemic blood gases and comfort for participants. Participants’ SO2 levels were carefully and 
continuously monitored while using this device. If the subject was uncomfortable or deemed at risk in any 
way the experiment was immediately terminated and 100% O2 was administered.  
Healthy young participants underwent spectral imaging of the retina and ONH for a series of stepped 
hypoxic and hyperoxic stimuli by varying the inspired portion of oxygen. For the hypoxic provocation, 
the study necessitated the use of a hypoxic stimulus of a PETO2 of 50 mmHg to provide effective 
dissociation of hemoglobin, which would be detectable at the level of retina. PETO2 was varied between 
baseline/normoxia (equivalent to sea level) and 50, 60 and 80mmHg. An end-tidal O2 of 50 mmHg is 
commonly used in physiological studies. For the hyperoxic provocation, PETO2 steps of 200, 300 and 
400mmHg were used to provide adequate vasoconstriction of the retinal arterioles. 
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3.2.3 Study Procedure 
Participants were seated for 15 minutes to allow stabilization of their hemodynamic parameters (heart rate 
and blood pressure) during which time they underwent a period of air-breathing. Medical tape (Tegaderm; 
3M Health Care, St. Paul, MN) was used to seal the facemask to the participants face. The facemask was 
connected to the RespirAct
TM 
sequential re-breathing gas delivery system. At the end of this stabilization 
period, pulse rate, resting blood pressure, retinal ODR and SPO2 measurements were taken at 
normoxia/baseline. Pulse rate, SPO2 and blood pressure were continuously monitored concurrently every 
2.5 minutes using a rapid response critical care gas analyzer (Cardiocap 5, Datex-Ohmeda, Helsinki, 
Finland) and transmitted electronically to a data acquisition system (S5 Collect, Datex-Ohmeda, USA). 
Two baseline ODR measurements were taken (BL1 and BL 2). During testing, the conditions in the lab 
were kept stable at an absolute pressure of 101.325 kPa (14.696 psi, 1 atm) and temperature of 20 °C 
(293.15 K, 68 °F). The study procedure is depicted diagrammatically in Appendix A. 
3.2.4 Statistical Analysis 
3.2.4.1 Measuring ODR with the HRC Device 
Retinal blood oximetry measurements were made in one major retinal arteriole and venule pair in the 
superonasal quadrant 1-2 disc diameters away from the ONH.  The analysis was done by comparing the 
reflected light intensity within a vessel to the intensity of light in the adjacent retina at isobestic (oxygen 
insensitive) and oxygen sensitive wavelengths. The Image J line tool was used to accurately determine the 
x, y coordinate of the selected point on the retina for blood SO2 measurements (Fig 3.1).  A line (three 
times the width of the vessel) was drawn perpendicular to the blood vessel and with customized macros 
using Image J (NIH) software. The value of maximum intensity of light reflected from the adjacent retinal 
background and the minimum value on the vessel measurement site (vessel intensity) are used to calculate 
OD and ODRs. This method of calculating ODR was adopted from Beach and co-workers (1999) 
9
 due to 
the current absence of a better algorithm. 
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Figure 3.1 The intensity of light reflected from the vessel is compared to that of the adjacent retina 
for both arterioles and venules  
………………………..18 
Where,  I0 is the intensity of light within the vessel 
 I is the intensity of light of the adjacent retina 
………………………….19 
Where, ODos is the optical density at an oxygen sensitive wavelength and  
ODi is the optical density at an isobestic (oxygen insensitive) wavelength 
Image processing techniques were carried out with the PHySpec V1.17.0 software on the acquired images 
so as to normalize and remove artifacts. The optic disk and superonasal regions of the fundus were then 
selected with the rectangle tool. The image cubes were then registered using a cross-correlation technique, 
with the 586nm image as reference. All other structures in the images were aligned to the coordinates of 
the reference image. Images were rotated and translated while comparing to the reference image for 
maximum cross-correlation. Image correction was done to stabilize and remove eye movement artifacts 
from image cubes.  
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Baseline (BL) measures of ODR were taken twice per study visit (BL 1 and BL 2). These baseline ODR 
measures were averaged to achieve mean baseline for each wavelength combination; 600/569nm, 
605/586nm, 610/ 548nm for all 10 participants. The range and SD of mean baseline ODR for each 
wavelength combination was also calculated to determine the variation per participant for each of the 10 
participants. In addition, the mean, range and SD of each baseline ODR measure (BL1 and BL2) were 
compared for each wavelength combination for all 10 participants to determine the variation. Results for 
arterioles and venules were computed separately for each wavelength combination. Due to the relatively 
small sample size, outliers (data points falling outside the 25
th
 to 75
th
 percentile) were maintained in the 
analysis. Statistica software (StatSoft, Inc., Tulsa, OK, USA) version 8.0 and Microsoft Excel 2010 was 
used for analysing the data. 
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3.3 Results 
3.3.1 ODR Variation in Arterioles for All Participants Comparing All Three Wavelength 
Combinations 
In arterioles, the group range (±SD) of ODR values for baseline measurements for n=10 (PETO2 of about 
100mmHg) was 0.169±0.061 for the 605/586 wavelength combination, 0.371±0.099 for the 600/569 
wavelength combination and 0.340±0.104 for the 610/548 wavelength combination (Table 3.2). The 
baseline ODR in arterioles for all three wavelength combinations (605/586, 600/569, 610/548) as a 
function of participant ID are shown in Figure 3.2. 
Participant ID# 
Mean Baseline ODRs in Arterioles for All Three Wavelength Combinations, 
600/586, 600/569 and 610/548 (n=10) 
600/586 600/569 610/548 
01 0.549 0.613 0.597 
02 0.678 0.718 0.622 
03 0.665 0.792 0.746 
04 0.607 0.791 0.706 
05 0.530 0.682 0.548 
06 0.586 0.681 0.560 
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07 0.549 0.741 0.529 
08 0.595 0.785 0.657 
09 0.671 0.752 0.612 
10 0.699 0.984 0.869 
Mean 0.613 0.754 0.644 
Range (Max-Min) 0.169 0.371 0.340 
SD 0.061 0.099 0.104 
Table 3.2 Arterioler ODR at mean baseline for 605/586, 600/569 and 610/548 for n=10 
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Scatterplot of ODR in Arterioles for all 3 Wavelength Combinations 
(605/586, 600/569, 610/548) for n=10
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Figure 3.2 Baseline ODR in arterioles for all three wavelength combinations (605/586, 600/569, 610/548) for n=10 
 
 
3.3.2 ODR Variation in Venules for All Participants Comparing All Three Wavelength 
Combinations 
In venules, the group range (±SD) of ODR values for baseline measurements for n=10 (PETO2 of about 
100mmHg) was 0.600±0.198 for the 605/586 wavelength combination, 0.569±0.169 for the 600/569 
wavelength combination and 0.819±0.274 for the 610/548 wavelength combination (Table 3.3). The 
baseline ODR in venules for all three wavelength combinations (605/586, 600/569, 610/548) as a function 
of participant ID are shown in Figure 3.3. 
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Participant ID# 
Mean Baseline ODRs in Venules for All Three Wavelength Combinations, 
600/586, 600/569 and 610/548 (n=10) 
600/586 600/569 610/548 
01 0.286 0.347 0.289 
02 0.739 0.667 0.878 
03 0.867 0.833 1.100 
04 0.544 0.621 0.870 
05 0.515 0.544 0.486 
06 0.434 0.469 0.462 
07 0.268 0.281 0.281 
08 0.320 0.378 0.459 
09 0.481 0.637 0.691 
10 0.646 0.851 0.747 
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Scatterplot of ODR in Venules for all 3 Wavelength Combinations 
(605/586, 600/569, 610/548) for n=10
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Figure 3.3 Baseline ODR in arterioles for all three wavelength combinations (605/586, 600/569, 610/548) for n=10 
 
 
Mean 0.510 0.563 0.626 
Range (Max-Min) 0.600 0.569 0.819 
SD 0.198 0.196 0.274 
Table 3.3 Venular ODR at Mean Baseline for 605/586, 600/569 and 610/548 for n=10  
 
 
 
58 
 
3.3.3 Comparison of Variation Between Baseline Measurements for All Participants and 
Wavelength Combinations 
3.3.3.1 605/586 Wavelength Combination 
 In arterioles, the group range (±SD) of ODR values of the 605/586 wavelength combinationat baseline 1 
and 2 was 0.607 ± 0.224 and 0.619 ± 0.158 respectively. In venules the group range (±SD) of ODR at 
baseline 1 and 2 was 0.289±0.750. and 0.284 ± 0.729 respectively ( Table 3.4). The baseline 1 and 2 
ODRs for the 605/586 wavelength combination as a function of participant ID are shown in Figure 3.4 
and 3.5 for arterioles and venules, respectively. 
 
 
 Variation in Baseline ODR with 605/586 (n=10) 
Participant ID# 
Arteriole Venule 
BL 1 BL 2 BL 1 BL 2 
01 0.532 0.565 0.289 0.284 
02 0.659 0.696 0.750 0.729 
03 0.635 0.696 0.845 0.889 
04 0.607 0.607 0.530 0.558 
05 0.488 0.572 0.514 0.516 
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Table 3.4 Variation in Baseline ODR with 605/586 (n=10) in arterioles and venules  
06 0.601 0.571 0.429 0.439 
07 0.560 0.539 0.252 0.283 
08 0.599 0.590 0.305 0.335 
09 0.677 0.665 0.494 0.469 
10 0.712 0.686 0.673 0.618 
Mean 0.607 0.619 0.508 0.512 
Range (Max-Min) 0.224 0.158 0.593 0.606 
SD 0.068 0.061 0.200 0.196 
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Box Plot of Baseline Measurement of ODR in Arterioles with 605/586
Combination of Wavelength (n=10)
Current effect: F(1, 9)=.89077, p=.36991
Median; Box: 25%-75%; Whisker: Non-Outlier Range
 Median 
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Figure 3.4 Boxplots representing repeat baseline measurements of ODR in Arterioles with 605/586 
Box Plot of Baseline Measurement of ODR in Venules with 605/586 Combination
of Wavelength (n=10)
Current effect: F(1, 9)=.14333, p=.71377
Median; Box: 25%-75%; Whisker: Non-Outlier Range
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Figure 3.5 Boxplots representing repeat baseline measurement of ODR in venules with 605/586 
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3.3.3.2 600/569 Wavelength Combination 
In arterioles, the group range (±SD) of ODR values with the 600/569 wavelength combination at baseline 
1 and 2 was 0.747±0.350 and 0.761±0.391, respectively. In venules the group range (±SD) of ODR at 
baseline 1 and 2 was 0.329±0.675 and 0.366±0.659, respectively (Table 3.5). The baseline 1 and 2 ODRs 
for the 600/569 wavelength combination as a function of participant ID are shown in Figure 3.6 and 3.7 
for arterioles and venules, respectively. 
 Variation in Baseline ODR with 600/569 (n=10) 
Participant ID# 
Arterioler Venular 
BL 1 BL 2 
01 0.607 0.619 0.329 0.366 
02 0.717 0.720 0.675 0.659 
03 0.825 0.759 0.843 0.823 
04 0.759 0.822 0.601 0.640 
05 0.667 0.697 0.573 0.514 
06 0.691 0.671 0.476 0.462 
07 0.769 0.713 0.284 0.279 
08 0.729 0.842 0.400 0.356 
09 0.746 0.758 0.665 0.609 
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10 0.957 1.011 0.836 0.865 
Mean 0.747 0.761 0.568 0.557 
Range (Max-
Min) 
0.350 0.391 0.559 0.586 
SD 0.095 0.110 0.196 0.197 
 
 
 
Box Plot of Baseline Measurement of ODR in Arterioles with 600/569
Combination of Wavelength (n=10)
Current effect: F(1, 9)=.70196, p=.42382
Median; Box: 25%-75%; Whisker: Non-Outlier Range
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Figure 3.6 Boxplots representing repeat baseline measurements of ODR in Arterioles with 600/569 
 
Table 3.5 Variation in Baseline ODR with 600/569 (n=10) 
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Box Plot of Baseline Measurement of ODR in Venules with 600/569 Combination
of Wavelength (n=10)
Current effect: F(1, 9)=.88250, p=.37205
Median; Box: 25%-75%; Whisker: Non-Outlier Range
 Median 
 25%-75% 
 Non-Outlier Range 
 Outliers
 Extremes
BL1 BL2
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
1.05
1.10
1.15
1.20
 
Figure 3.7 Boxplots representing repeat baseline measurements of ODR in venules with 600/569  
 
3.3.3.3 610/548 Wavelength Combination 
In arterioles, the group range (±SD) of ODR values with the 610/548 wavelength combination at baseline 
1 and 2 was 0.604±0.263 and 0.685±0.450, respectively. In venules, the group range (±SD) of ODR at 
baseline 1 and 2 was 0.292±0.746 and 0.285±1.009, respectively (Table 3.6).  The baseline 1 and 2 ODRs 
for the 610/548 wavelength combination as a function of participant ID are shown in Figure 3.8 and 3.9 
for arterioles and venules, respectively. 
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 Vsriation in Baseline ODR with 610/548 (n=10) 
Participant ID# 
Arterioler Venular 
BL 1 BL 2 BL 1 BL 2 
01 0.558 0.635 0.292 0.285 
02 0.609 0.635 0.746 1.009 
03 0.649 0.843 1.062 1.138 
04 0.708 0.703 0.871 0.868 
05 0.491 0.605 0.489 0.484 
06 0.525 0.596 0.483 0.442 
07 0.505 0.553 0.256 0.305 
08 0.550 0.764 0.451 0.466 
09 0.691 0.533 0.654 0.728 
10 0.755 0.983 0.732 0.761 
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Table 3.6 Variation in Baseline ODR with 610/548 (n=10) 
 
 
 
Box Plot of Baseline Measurement of ODR in Arterioles with 610/548
Combination of Wavelength (n=10)
Current effect: F(1, 9)=4.7899, p=.05638
Median; Box: 25%-75%; Whisker: Non-Outlier Range
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Figure 3.8 Boxplots representing baseline measurement of ODR in arterioles with 610/548  
 
Mean 0.604 0.685 0.604 0.649 
Range (Max-Min) 0.263 0.450 0.806 0.852 
SD 0.093 0.141 0.256 0.296 
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Box Plot of Baseline Measurement of ODR in Venules with 610/548 Combination
of Wavelength (n=10)
Current effect: F(1, 9)=2.7526, p=.13147
Median; Box: 25%-75%; Whisker: Non-Outlier Range
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Figure 3.9 ODR (610/548) Boxplots representing baseline measurement of ODR in venules with 
610/548 
 
In summary, the total group range ±SD of ODR values at baseline in arterioles for the 605/586 
wavelength combination was 0.169±0.061, 600/569 wavelength combination was 0.371±0.099 and 
610/548 wavelength combination was 0.340±0.104 (Table 3.7). In venules, the total group range ±SD of 
ODR at baseline for the 605/586 wavelength combination was 0.600±0.198, 600/569 wavelength 
combination was 0.569±0.196 and 610/548 wavelength combination was 0.819±0.274 (Table 3.8).  
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Table 3.7 Total Variation in Mean ODR for three Wavelength Combinations ± SD in Arterioles  
 
 Wavelength Combinations for Calculating ODR±SD 
Total Variation in ODR 
(Venules) 
605/586 600/569 610/548 
Range 0.600 0.569 0.819 
Standard Deviation (SD) 0.198 0.196 0.274 
Table 3.8 Total Variation in Mean ODR for three Wavelength Combinations ± SD in Venules  
 
There was no statistical significance reported between baseline ODR values (BL1 and BL2) for n=10 with 
all three wavelength combinations in arterioles and venules; for the 605/586 wavelength combination, p = 
0.370 in arterioles and p = 0.714 in venules. 600/569 combination, p = 0.424 in arterioles and p = 0.372 in 
venules and for the 610/548 combination, p = 0.056 arterioles and p = 0.131 in venules (Table 3.9). 
 
 Wavelength Combinations for Calculating ODR±SD 
Total Variation in ODR 
(Arterioles) 
605/586 600/569 610/548 
Range 0.169 0.371 0.340 
Standard Deviation (SD) 0.061 0.099 0.104 
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 Difference Between Baseline Measurements  
P-value (α=0.05) 605/586 600/569 610/548 
Arterioles 0.370 0.424 0.056 
Venules 0.714 0.372 0.131 
Table 3.9 Differences between baseline measurements for all 3 wavelength combinations (600/586, 600/569, 610/548) 
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3.4 Discussion and Conclusion 
Of the three wavelength combinations selected, the 605/586 combination was shown to have the least 
variability in arterioles and venules with a range and SD of 0.169±0.061 in arterioles and range and SD 
of 0.600±0.198 in venules. The 600/569 combination were also found to be consistently higher across 
all 3 wavelength combinations in arterioles than in venules. It was also found that the variability was 
generally larger in measuring ODR in venules than in arterioles for all 10 participants. There was no 
statistical significance observed between baseline ODR values (BL1 and BL2) for n=10 with all three 
wavelength combinations in arterioles and venules. The lack of statistical significance observed was 
consistent with what we expected, as a healthy individual’s baseline ODR does not change especially 
with measurements taken within minutes of each other. This range and SD in arterioles with the 
605/586 combination was in comparison to 0.371±0.099 for 600/569 wavelength combination and the 
610/548 wavelength combination which had a range ± SD of 0.340±0.104.  In venules, the range and 
SD with the 605/586 combination was in comparison to 0.569±0.196 for 600/569 combination and 
0.819±0.274 for the 610/548 combination. The least variability of the 605/586 wavelength combination 
in arterioles and venules presupposed that it was the most reliable in terms of measuring ODR in 
arterioles and venules with our prototype device.  These observations were made when the three 
wavelength combinations were used to image primary/first degree arterioles and venules within the 
superonasal region of the fundus within 1-2 optic disc diameters away from the optic disk with the 
prototype HRC device. 
The 605/586 wavelength combination has produced consistently reliable results in a number of previous 
studies in healthy and diseased states of the posterior fundus with noninvasive spectrophotometric 
oximetry 
10, 10, 168, 184, 186, 199, 200
. Hardarson and co-workers (2006) measured SO2 in retinal vessels and 
tested the reproducibility and sensitivity of an automatic spectrophotometric oximeter 
168
. For repeated 
measurements, the mean SD was 3.7% for arterioles and 5.3% in venules, in terms of retinal blood SO 2 
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in first degree vessels. Measurements were inferior and superior to the ONH. All images were acquired 
in the dark. 
The 600/570 ODR has been used by Geirsdottir and co-workers (2012) with the Oxymap T1 (Oxymap 
ehf., Rejkjavik, Iceland) noninvasive dual-wavelength spectrophotometric retinal oximeter 
153
. 600 and 
570 wavelengths have also been used previously to determine choroidal oximetry and to validate 
spectrophotometric retinal oximetry in the pig 
201, 202
. 
610/548 ODR has been used with some success in some systems 
173, 187, 188, 193, 203, 204
. Hammer and co-
workers (2008) measured the sensitivity and reproducibility of retinal SO2 measurements in retinal 
vessels using a fundus camera and a semi-automated vessel recognition system. SDs of 2.52% and 
3.25% SO2 were recorded for arterioles and venules, respectively, when measurements of the identical 
vessel segments of five images per participant were made 
203
. Michelson and co-workers (2006) 
188
 
derived retinal SO2  measures using the same wavelengths using a prototype spectrometer (University 
Jena, Germany). A single arteriole was analyzed. The Palkovits and co-workers (2013) study on the 
other hand measured retinal SO2 in participants with chronic obstructive pulmonary disease with a 
retinal vessel analyzer (RVA) combined to an oxygen module (Imedos, Jena, Germany) 
193
. The 
modified RVA made measurements of retinal SO2 in all vessels in a peripapillary annulus with an inner 
radius of 1 and an outer radius of 1.5 disc diameters and averaged over all arterioles and venules. The 
Lasta and co-workers (2012) study also made use of a RVA with the 610 and 548 wavelengths. This 
study determined the reproducibility of retinal SO2 in healthy participants measured with the device. 
The intraclass correlation coefficients were between, 0.91-0.94; and between 0.84-0.88 for retinal 
branch arterioles and venules, respectively 
204
. 
The choice of the most reliable wavelengths to calculate ODR and subsequent retinal SO2 appears to be 
dependent on a variety of parameters such as the specifications and/or limitations of the imaging system 
adopted and the choice of quadrant within the fundus for imaging. In the Geirsdottir and co-workers 
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(2012) study, retinal SO2 arteriolar measures in the inferotemporal quadrant  had significantly lower 
oxygen saturation values compared to the superotemporal, inferonasal and superonasal quadrants of the 
retina
153
. Shahidi and co-workers (2013) also found greater retinal blood SO2 values in the superior 
temporal first degree retinal arterioles and venules in young healthy individuals than in the equivalent 
inferior vessels 
205
.  
The Oxymap oximeter is generally similar to the HRC prototype device used in this study. Differences 
lie primarily in the Oxymap’s use of a flash system and less importantly, a semi-automatic vessel 
detection technique and its analysis of all vessels (arterioles and venules) simultaneously. With the 
HRC prototype, only a single arteriole is typically analyzed for retinal SO2, as in the Michelson and co-
workers (2006) study 
188
. It therefore comes as no surprise that, like the Hardason group, our device 
shows almost identical SDs for both the 605/586 and 600/569 ODRs as compared to the 610/548 ODR 
which have both been used successfully in previous studies with the Oxymap system. It appears 
however that the 605/586 ODR was been used with more success and reliability; a finding that has been 
confirmed by this study. This study appears to be the first to look at the reliability of ODRs by 
comparing the variability of ODRs acquired in a specific spectrophotometric imaging system. 
3.4.1 Summary 
The 605/586 combination out of all the 3 wavelength combinations (605/586, 600/569 and 610/548) 
considered was shown to have the least variability in arterioles and venules with the prototype HRC 
used in the study. 
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4 The Effect of Change in Oxygen Tension on Total Retinal Blood Flow and Retinal Oxygen 
Saturation in Healthy Participants  
4.1 Introduction 
Hypoxia of the retina causes vasodilation of the retinal arterioles beginning at Hb SO2 below 90% and can 
be measured clearly below 65mmHg 
61, 70
. Hyperoxia occurs as a result of an increase in PETO2 above 
normal (>100mmHg) resulting in vasoconstriction of the inner retinal arteriolar vessels and a decrease in 
retinal blood flow 
3, 64, 65
. Vasoconstriction of the retinal arterioles serves as a regulatory response for 
keeping the PO2 in retinal tissue constant, despite the fact that the hyperoxic levels required to initiate this 
response are not physiological. Reduced retinal capillary and ONH blood flow has been seen in smokers, 
secondary to hyperoxia 
66
. 
In vivo oxygen profiles have been demonstrated and are similar in the rat, pig and cat. In the monkey, 
differences occur in the fovea as compared to the other animals. When the rods are fully saturated with 
light (light adaptation), there is a significant fall in oxygen tension of about 60mmHg from the 
choriocapillaris to the inner segments of the photoreceptors, with further decreases through the outer 
retina. This fall in oxygen tension indicates that in light adapted conditions, the choroid provides all the 
oxygen for consumption by the photoreceptors. On the other hand, in a dark adapted retina, retinal oxygen 
tension values are considerably lower than that in the light adapted retina indicating that oxygen also 
diffuses from the retina to the photoreceptors 
11
. 
In conditions of normoxia in healthy participants, PETO2 and PETCO2 values vary depending on a number 
of biological factors such as gender, height, weight, age and medical history. Generally speaking 
however, PETO2 values vary between about 75-100mmHg (10-13kPa) 
71
 and PETCO2 about 34-45mmHg 
(4.5-6.0kPa) 
72
. Arterial blood oxygen saturation (SaO2) and venous blood oxygen saturation (SvO2) is 
about 95-100% 
72
 and 60-80% 
206
saturation of Hb molecules in arterial and venous blood, respectively. 
TRBF varies inversely with PETO2 in order to keep retinal SO2 somewhat constant 
3, 3, 207
. 
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Very few studies have assessed both retinal SO2 and RBF 
154, 173, 175, 208
. In one such study by Siesky and 
co-workers (2010) 
175
, retinal vessel SO2 did not change while RBF increased with the administration of 
dorzolamide/timolol treatment over an eight month period for each drug; suggesting an increase in 
oxygen delivery with an increase in blood flow. Dorzolomide had been shown in previous studies to 
increase optic nerve PO2 in animal models and the same is suggested to occur in humans 
209-211
.  In a 
separate study by the same group on the administration of dorzolamide/brinzolamide treatment over a 3 
month period per drug, it was shown that both retinal SO2 and RBF increased in patients with primary 
open-angle glaucoma 
211
. Hammer and co-workers (2011), used laser Doppler velocimetry to determine 
an increased blood velocity and vessel diameters during flicker stimulation. In addition, arteriolar and 
venular SO2 was determined using dual wavelength (548nm and 610nm) optical oximetry fundus images 
173
. Another study by Sebag and co-workers (1989) looked at optic atrophy and the effects it had on 
retinal blood flow and SO2 
154
. Retinal SaO2 for temporal and nasal regions of affected eyes was 
determined by retinal vessel oximetry. Frayser and co-workers (1974) also looked at retinal blood flow 
and SO2 at an altitude. Retinal blood flow was measured in otherwise normal volunteers who had been at 
an altitude 17,500ft for 5-9 days. Retinal blood flow was double that normally observed at sea level 
208
. 
Several studies have focused solely on RBF measurements with the Doppler FD-OCT device 
212-219
.  
In this study, a novel HRC with a prototype fundus camera, a tunable laser source based on the Bragg 
grating filtering technology and a high definition CCD camera with a bandwidth of 2nm (FWHM) were 
used. Three wavelength combinations (ODR-s) were separately employed (600 and 569nm, 605 and 
586nm, 610 and 548nm) for the analysis. Other spectral cameras, unlike the HRC, make  use  of  a  
snapshot  flash  system that bleaches the photopigments and therefore alters reflectance characteristics of  
the  fundus and subsequently affects derivation of accurate ODR readings. In addition, a Doppler FD-
OCT device which enables the determination of TRBF by summing the flow of blood from all branch 
venules at one time is used. The study looks at the quantification of retinal blood SO2 with the 605/586 
wavelength combination and investigates the relationship between total retinal blood flow and retinal SO2 
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in vessels of normal, healthy study participants under conditions of normoxia, hypoxia, and hyperoxia 
while maintaining isocapnia. TRBF and retinal SO2 are expected to relate inversely with each other in 
hyperoxia and hypoxia. 
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4.2 Materials and Methods 
4.2.1 Sample 
Ethical clearance was obtained from the University Health Network Research Ethics Board, Toronto and 
the University of Waterloo, Office of Research Ethics prior to the start of the study. After explaining the 
study and its possible consequences to each study participant according to the Declaration of Helsinki, 
informed consent was obtained from each participant. The study sample of ten healthy participants (five 
females and five males) between the ages of 23 and 37, with an average age 28.3 years (SD 3.90) was 
recruited for the study from the School of Optometry and Vision Science, University of Waterloo and 
Department of Ophthalmology and Vision Sciences, University of Toronto. Of the 10 recruited, 1 was of 
Middle Eastern, 3 were of Black/African, 2 were of Asian, 2 were of White and 2 were of Indian descent. 
The right eye of each participant was chosen for the study for convenience of use with the prototype 
HRC. 
Participants with distance refractive errors > ± 6.00 DS and/or ± 2.50 DC, any indication or history of 
chronic / serious eye disease (glaucoma, diabetes, or any ocular disease permanently affecting vision or 
requiring surgery) in self or first degree relative or systemic disease (endocrine disorders, 
hypercholesterolemia, etc.), strok-e or chronic obstructive/restrictive lung disease (such that the volunteer 
is unable to walk up 2 flights of stairs, i.e. does not include seasonal asthma) or on any medications with 
known vascular effects (e.g. antioxidants, blood pressure medication) were excluded from the study. In 
addition, participants who were unable to cope with the breathing protocol, e.g. due to claustrophobia, 
those who were habitual smokers (or quit smoking within past 6 months), or those who showed non-
compliance with prescribed anti-seizure medication or people who demonstrated a resting arterial SO2 
while breathing room air < 95 % were also excluded. Participants were asked to refrain from vitamin C, 
caffeine, red meat, chocolate, alcohol and exercise for at least 12 hours prior to the study visit. 
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4.2.2 Study Visits 
Participants attended a single 140 minute study visit scheduled between 9 and 11am for all participants. 
Two gas provocation protocols; hyperoxia (200, 300, 400mmHg) followed by hypoxia (80, 60, 50mmHg) 
were administered in a fixed sequential order.  Each protocol consisted of four phases of differing PETO2 
with three repeat measurements at each step in the order; For hyperoxia, PETO2 of 100mmHg (i.e. 
normoxia), 200mmHg, 300mmHg, 400mmHg were utilised. For hypoxia, PETO2 of 100mmHg, 80mmHg, 
60mmHg and 50mmHg were utilised. Each phase was maintained for 10minutes, except for the 
normoxia/baseline phase which was maintained for 15 minutes. In each phase of gas provocation (PETO2), 
retinal SO2 and TRBF measurements were made with the HRC and Doppler FD-OCT. 
4.2.3 Novel Hyperspectral Retinal Camera  
This prototype device allows for two-dimensional spectral and spatial information to be recorded 
in a single exposure 
173
. The instrument comprises a custom made mydriatic fundus camera with a 
tunable laser source (TLS) allowing for observance of the fundus at wavelengths ranging from 420 
to 1,000nm at safe and comfortable illumination levels. The TLS is based on the Bragg grating 
filtering technology from Photon etc. which allows for rapid and accurate (<1nm) wavelength selection 
from the supercontinuum source. For high definition imaging, it contains a sensitive CCD camera and 
spectral reproducibility in time is assured with a built in calibration system 
171
. The CCD sensor has a 
dynamic range of 14bits, and pixel scan rate and data rate of 12MHz/24MHz and 19.5 Mpixel/s 
respectively. The spectral range of the sensor is 290nm to 1100nm. Two-dimensional images of the 
retina are recorded and registered to produce a spectral (i.e. third dimension is colour) cube while 
assuring patient comfort. The image capture time of the HRC is 80ms. A 2x2 binning mode was used 
with an effective pixel resolution of 696x520 pixels.  
4.2.4 Gas Delivery System (RespirActTM, Thornhill Research Inc., Toronto, Canada)  
The gas delivery system employed in the study was made up of a sequential re-breathing gas delivery 
circuit (Hi-Ox80, Viaya Healthcare, Yoruba Linda, CA). The circuit which was attached to participants 
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via a facemask was made up of a commercial 3-valve oxygen delivery system with a rebreathing bag on 
the exhalation port.  Participants breathed previously exhaled gas from the rebreathing bag when the 
contents of the fresh gas reservoir were depleted. The circuit was in turn connected to an automated gas 
flow controller (RespirAct
TM
, Thornhill Research Inc. Toronto, Canada) and blender that has been 
primarily developed and employed for the purposes of gas provocation by the Fisher laboratory at 
University of Toronto for over a decade. Similarly, Hudson laboratory have contributed to the 
development of the instrument from the beginning and have used it for over a decade. The device enables 
the precise control of the partial end tidal pressures of oxygen (PETO2) and carbon dioxide (PETCO2) by 
modulating the inspired portion of oxygen and carbon dioxide, it is possible to accurately and repeatedly 
generate stable controlled and safe levels of hypoxia and hyperoxia. This technique uniquely targets exact 
pre-determined PO2 levels and sustains them while maintaining isocapnia over the pre-determined phase 
duration irrespective of the individuals’ respiratory rate. PETO2 and PETCO2 accurately measures PaO2 and 
PaCO2 respectively when breathing using the RespirAct
TM
 sequential re-breathing gas delivery system 
150, 
197
. The benefits of using this technique include the avoidance of under or overshooting the desired PETO2 
and PETCO2 hence the consistency of data is improved. Also, safety improves since the risk of 
overshooting the target end-tidal gases into dangerous levels are eliminated providing improved, 
sustained safety and comfort for participants. Participants’ systemic SO2 levels were carefully and 
continuously monitored while using this device. If the subject is uncomfortable, deemed at risk in any 
way the experiment was immediately terminated and 100% O2 was administered.  
Healthy young participants underwent spectral imaging of the retina and ONH for a series of stepped 
hypoxic and hyperoxic stimuli by varying the inspired portion of oxygen. For the hypoxic provocation, 
the study necessitates the use of a hypoxic stimulus of a PETO2 of 50mmHg to provide effective 
dissociation of hemoglobin, which would be detectable at the level of retina. PETO2 was varied between 
baseline/normoxia and 50, 60 and 80mmHg. An end-tidal O2 of 50 mmHg is commonly used in 
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physiological studies. For the hyperoxic provocation, PETO2 steps of 200, 300 and 400mmHg were used to 
provide adequate vasoconstriction of the retinal arterioles. 
4.2.5 RTVue Doppler FD-OCT 
Once the Doppler scans are acquired, they are integrated together with a 3D disk scan exported as raw 
data from the RTVue instrument using a custom made transfer output software. The data was then 
converted with ReVue software (Optovue Inc.) into a format compatible with the DOCTORC software 
(version 2.1.1.4); which is used for assessment and identification of candidate vessel locations and vessel 
boundaries by an initial automated assessment. Retinal vessels are also identified as either arterioles or 
venules based on the Doppler signal 
147
. 
Doppler scans are then registered with the OCT projection image, infrared scanning laser ophthalmoscopy 
(SLO) image. A human grader is then able to manually grade the Doppler signals by correlating vessels 
seen on the Doppler FD-OCT cross sectional B-scans with those visible on the en-face images 
147
. A 
colour fundus image is required to verify the automatic vessel assessment location and identification of 
arterioles/venules by DOCTORC (Fig 4.1). The grading procedure may include adjusting vessel locations 
and size, matching corresponding vessels on the two concentric rings, adding missing vessels, deleting 
extraneous vessels, verifying the classification of the vessel type and allocating a confidence score 
ranging from 0 to 5 to reflect the graders certainty of accuracy of grading. The confidence score is 
allocated based on several factors such as Doppler signal strength of the vessel, vessel size agreement 
between the two concentric rings and clarity of vessel boundaries 
147
. With completion of grading, 
DOCTORC software then computes blood flow results and automatically exports them into a folder 
specified per subject.  
4.2.3 Study Procedure 
Participants were seated for 10 minutes to allow stabilization of their hemodynamic parameters (heart rate 
and blood pressure) during which time they underwent a period of air-breathing. Medical tape (Tegaderm; 
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3M Health Care, St. Paul, MN) was used to tightly seal the facemask to the participants face – The 
facemask was connected to the RespirAct
TM
 sequential re-breathing gas delivery system. At the end of 
this stabilization period, pulse rate, resting blood pressure, retinal blood SO2, SPO2 and TRBF baseline 
measurements were taken at normoxia. Participants then underwent the further phases of the gas 
provocation protocol. In each phase of the provocation (hyperoxia and hypoxia), retinal blood SO2 and 
TRBF was measured with the HRC and Doppler FD-OCT systems during the last 5 minutes of the phase. 
Pulse rate, SPO2 and blood pressure rate was also monitored concurrently every 2.5 minutes using a rapid 
response critical care gas analyzer (Cardiocap 5, Datex-Ohmeda, Helsinki, Finland) and transmitted 
electronically to a data acquisition system (S5 Collect, Datex-Ohmeda, USA). A period of 15 minutes was 
allowed for the individual’s metabolic measures to return to baseline in between provocation challenges 
and about 5 minutes between every specific provocation. During testing, the conditions in the lab was 
kept stable at an absolute pressure of 101.325 kPa (14.696 psi, 1 atm) and a temperature of 20 °C 
(293.15 K, 68 °F). The study procedure is depicted diagrammatically in Appendix B and C. 
4.2.4 Statistical Analysis 
4.2.5.1 Measuring ODR with the HRC Device 
Retinal blood oximetry measurements were made in one major retinal arteriole and venule pair in the 
superonasal quadrant 1-2 disc diameters away from the ONH.  The analysis was done by comparing the 
reflected light intensity within a vessel to the intensity of light in the adjacent retina at isobestic (oxygen 
insensitive) and oxygen sensitive wavelengths. The Image J line tool was used to accurately determine the 
x, y coordinate of the selected point on the retina for blood SO2 measurements (Fig 3.1).  A line (three 
times the width of the vessel) was drawn perpendicular to the blood vessel and with customized macros 
using Image J (NIH) software. The value of maximum intensity of light reflected from the adjacent retinal 
background and the minimum value on the vessel measurement site (vessel intensity) are used to calculate 
OD and ODRs. This method of calculating ODR was adopted from Beach and co-workers (1999) 
9
 due to 
the current absence of a better algorithm. 
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Figure 4.4.1 The intensity of light reflected from the vessel is compared to that of the adjacent 
retina for both arterioles and venules 
………………………..18 
Where,  I0 is the intensity of light within the vessel 
 I is the intensity of light of the adjacent retina 
………………………….19 
Where, ODos is the optical density at an oxygen sensitive wavelength and  
ODi is the optical density at an isosbestic (oxygen insensitive) wavelength 
Image processing techniques were carried out with the PHySpec V1.17.0 software on the acquired images 
so as to normalize and remove artifacts by subtraction of a normalisation and beam dump cube. The optic 
disk and superonasal regions of the fundus were then selected with the rectangle tool. The image cubes 
were then registered using of a cross-correlation technique, with the 586nm image as reference. All other 
structures in the images were aligned to the coordinates of the reference image. Images were rotated and 
translated while comparing to the reference image for maximum cross-correlation. Image correction was 
done to stabilize and remove eye movement artifacts from image cubes.  
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The 605/586 wavelength combination which was found in the previous study to have the least variability 
of three wavelength combinations (605/586, 600/569 and 610/548) with our device, was used in the 
current study. Systemic SO2 (SPO2) values for all 10 participants were compared for consistency of 
results. Data for six participants were subsequently excluded due to inconsistencies. The Mean ODR for 
arterioles and venules was then computed for the 4 selected participants and used to calculate retinal 
blood SO2 at baseline in arterioles and venules according to the equation: 
………………..20 
Boxplots of retinal blood SO2 in venules (SvO2) and arterioles (SaO2) were subsequently formed to 
compare the two parameters.  
TRBF (ul/min), SaO2 (%) and SvO2 (%) was then determined for each step of PETO2 (BL1, 200, 300, 400, 
BL2, 80, 60 and 50 mmHg) and grouped for all ten participants recruited. Separate retinal SO2 equations 
were determined in arterioles and venules per provocation step. To investigate the relationship between 
TRBF, SaO2 and SvO2 with PETO2, mean values of TRBF, SaO2 and SvO2 were computed per participant 
and per each of the 8 provocation steps. These- values (8 per participant) were then grouped together for 
each of the three parameters (80 data points in all per parameter). TRBF was then plotted against retinal 
SO2 separately for arterioles and venules in scatterplots to determine the correlation between each 
parameter with the Pearson’s correlation coefficient (r) and p-values (α = 0.05) were determined for the 
correlation. Statistica software (StatSoft, Inc., Tulsa, OK, USA) version 11.0 and Microsoft Excel 2010 
was used for analyzing the data. Significance was pegged at p<0.05. Due to the small sample population 
employed, all outliers were included in the correlation analysis. 
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4.3 Results 
4.3.1 HRC Systemic SO2 Data for n=9 
The systemic SO2 values for each individual for the HRC and Doppler FD-OCT are shown in Tables 4.1 
and 4.2, respectively. 
Subject 
ID# 
Systemic SO2 
PETO2, 
400 
mmHg 
PETO2, 
300 
mmHg 
PETO2, 
200 
mmHg 
BL1 BL2 
PETO2, 80 
mmHg 
PETO2, 60 
mmHg 
PETO2, 50 
mmHg 
02 100 99 100 98 99 97 93 91 
03 99 99 98 97 99 94 90 86 
04 97 98 97 97 97 94 92 89 
05 99 99 99 100 100 99 93 87 
06 99 99 99 97 99 92 88 88 
07 99 99 98 99 99 95 90 90 
08 99 99 99 99 99 98 93 89 
09 100 100 100 100 100 96 92 70 
10 100 100 100 100 100 97 90 84 
Mean 98.56 98.89 99.11 99.11 99.11 95.78 91.22 86.00 
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SD 1.33 1.05 0.60 0.93 0.93 2.22 1.79 6.36 
Table 4.1 Systemic SO2  per PETO2 for n=9 during HRC measurements. 
4.3.1 RtVue Systemic SO2 Data for n=9 
Subject 
ID# 
Systemic SO2 
PETO2, 
400 
mmHg 
PETO2, 
300 
mmHg 
PETO2, 
200 
mmHg 
BL1 BL2 
PETO2, 80 
mmHg 
PETO2, 60 
mmHg 
PETO2, 50 
mmHg 
02 99 98 98 98 99 99 100 99 
03 100 99 99 99 99 99 100 100 
04 99 99 99 100 99 99 100 100 
05 100 98 99 100 99 99 100 100 
06 100 98 98 98 99 99 100 99 
07 97 94 97 97 97 96 99 97 
08 95 95 92 92 92 92 95 91 
09 80 86 88 88 89 89 91 85 
10 99 98 98 98 99 99 100 99 
Mean 98.89 99.44 99.44 99.44 99.00 96.78 92.44 86.67 
SD 0.78 0.53 0.53 0.73 0.87 1.30 2.30 3.32 
Table 4.2 Systemic SO2  per PETO2 for n=9 during Rtvue measurements  
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4.3.2 Quantification of Retinal Blood SO2 at baseline with 605/586 Wavelength Combination 
The mean retinal blood SO2 value at baseline in arterioles for 4 participants was 95.19% ± 31.04% and 
venules was 53.89% ± 17.24%, p = 0.115 (Table 4.3).  The baseline ODR and retinal SO2 values for 
arterioles and venules are shown in Figure 4.1 
Subject ID# ODR in Arterioles ODR in Venules SaO2 (%) SvO2 (%) 
04 0.624 0.530 105.419 68.730 
05 0.488 0.514 52.518 62.554 
06 0.601 0.429 96.598 29.467 
09 0.677 0.494 126.227 54.794 
Mean 0.5975 0.4917 95.190 53.89 
SD 0.079 0.0442 31.042 17.25 
Table 4.3 ODR and retinal SO2 baseline measurements for 4 participants in venules and arterioles 
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Box Plots Representing SaO2 (%) and SvO2 (%) (n=4)
Current effect: F(1, 3)=4.8377, p=.11523
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Figure 4.2 Box plots representing baseline retinal SO2 values for 4 participants. 
 
4.3.2 Relationship between Retinal Blood SO2 and Retinal Blood Flow 
There was a negative linear relationship between retinal blood SO2 and TRBF values in the 10 
participants studied. The Pearson’s correlation coefficient (r) between TRBF and SaO2 was r = -0.354 and 
p = 0.001. The Pearson’s correlation coefficient (r) between TRBF and SvO2 was r = - 0.295, p = 0.008 
(Table 4.4). The Mean (±SD) of TRBF and retinal blood SO2 values for 10 participants are shown in 
Figure 4.2 and 4.3. 
 Mean ± SD 
SUBJECT ID# TRBF (µl/min) SvO2 (%) SaO2 (%) 
01 30.11±6.49 -0.84±33.77 72.14±6.53 
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02 20.70±7.71 106.49±35.16 101.16±27.83 
03 15.03±6.77 145.05±41.73 112.96±16.07 
04 19.79±4.83 58.30±20.09 92.227±13.91 
05 23.22±8.22 43.10±19.43 76.58±19.56 
06 25.99±6.72 38.46±21.76 85.75±6.98 
07 21.72±5.40 -21.13±27.28 78.62±12.76 
08 21.84±4.63 5.39±27.13 93.75±10.90 
09 20.96±2.44 60.05±18.45 115.92±14.37 
10 19.79±2.93 105.14±10.93 120.85±18.89 
Table 4.4 Table showing mean ±SD TRBF and retinal SO2 values in arterioles and venules for each of 10 participants. 
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Scatter plot of TRBF (ul/min) Against SaO2 (%)
r = - 0.3540, p = 0.0013
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Figure 4.3 Scatter plot of TRBF against SaO2 across all 8 provocation steps (n=10) 
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Scatterplot of TRBF (ul/min) Against SvO2 (%)
r = - 0.2947, p = 0.0080
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Figure 4.4 Scatter plot of TRBF against SaO2 across all 8 provocation steps (n=10) 
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4.4.0 Discussion and Conclusion 
4.4.1 Quantification of retinal blood SO2 at baseline  
The mean ± SD absolute value of retinal blood SO2 in the arterioles (SaO2) was found to be 95.19% ± 
31.04% and was 53.89% ± 17.24% in the venules (SvO2). These absolute values (SaO2 and SvO2) at 
baseline for the 4 participants fell within the range expected and described in the literature 
9, 153, 168
. The 
difference between the two parameters were not statistically significant (p=0.12). The lack of significance 
was believed to be due to the presence of significant variation in the retinal SO2 values (and overlap of the 
two parameters), especially in the arterioles, and also the small sample size utilised. However, the 
magnitude of the difference between the two parameters was high and consistent with the low flow, high 
oxygen exchange vascular system typical of the retinal vascular system. 
Calibration was performed with separate SO2 equations per provocation step. Retinal blood SO2 
calculated showed considerable high inter-subject variability and unrealistic calculated retinal SO2 values 
such as values beyond the physiological range (0-100%) i.e. above 100% and some calculated negative  
values. Similar high inter-subject variability (especially in SvO2) have been reported by Mordant and co-
workers (2011) who also used a hyperspectral imaging technique similar to the one used in this study 
157
. 
Hardarson and co-workers (2012) in their study on diabetic patients found a retinal blood SO2 93±4% in 
the retinal arterioles of healthy volunteers at normoxia and 58±6% in venules (mean±SD, n=31) 
186
.  Another study by the same group 16 participants found that retinal SaO2 measured 96% ± 9% (mean 
± SD) during normoxia. In a study by Beach and co-workers in 1999, SvO2 in ten participants was 
observed at normoxia and corrected for choroidal pigmentation. Mean SvO2 was reported as 55% ± 3.39% 
(SE) with a range of 26% among subjects at normoxia 
9
. Geirsdottir and co-workers (2012) determined 
the retinal SO2 in 120 healthy individuals with the Oxymap T1 retinal oximeter. SaO2 was 92.2% ± 3.7% 
and SvO2 was reported as 55.6% ± 6.3% 
153
 at normoxia. 
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4.4.2 Relationship between Retinal SO2 and Retinal Blood Flow 
TRBF was found in this study to relate inversely with SaO2 and SvO2 with a Pearson’s correlation 
coefficient of r = -0.354 and p = 0.001 for arterioles. Similarly, an r = – 0.295 and p=0.008 was 
determined for the relationship between TRBF and SvO2. The inverse relationship reported was consistent 
with current literature 
3, 3, 207
. 
Very few studies have looked at both blood flow and retinal SO2 concurrently. Hammer and co-workers 
(2011) in their experiment used laser Doppler velocimetry to determine an increased blood velocity and 
vessel diameters during flicker stimulation. In addition, arteriolar and venous retinal SO2 was determined 
using dual wavelength (548nm and 610nm) optical oximetry fundus images. SaO2 remained constant at 
98%-99%, with an increase in SvO2 from 60% ± 5.7% to 64% ± 5.9% (P<0.0005) under flicker 
stimulation. The diameter of central retinal arteries and veins increased significantly from 193± 20µm to a 
maximum of 202 ± 19µm (P<0.001); 5.6% ± 4.9% and from 228 ± 20µm to 242 ± 17µm (P<0.001); 7.6% 
± 3.4%, respectively, suggesting an increase in retinal blood velocity 
173
. A relatively old but relevant 
study by Sebag and co-workers in 1989 looked at optic atrophy and the effects it had on retinal blood 
flow and SO2 
154
. Retinal SaO2 for temporal and nasal regions of affected eyes was determined by retinal 
vessel oximetry.  In this study, arteriovenous SO2 values were 12% ± 9% higher in eyes affected by optic 
atrophy in 7 participants.  Arteriovenous blood flow measured with LDV was 48% ±20% lower in 4 
participants also with optic atrophy. Retinal blood flow rates in temporal retinal arterioles of affected eyes 
were found to be 23.5µl/min and 12.3µl/min for the fellow and affected eyes, respectively. The average 
percent difference was - 48%, reflecting a significant reduction in blood flow in the affected eyes (P = 
0.017) 
154
. Frayser and co-workers (1974) also looked at retinal blood flow and SO2. Retinal blood flow 
was measured in otherwise normal volunteers who had been at an altitude 17,500ft for 5-9 days. Retinal 
blood flow doubled that normally observed at sea level at SaO2 of 70 ± 3%. RBF after 9 days at the 
altitude was 331ml/100g-1min-1 
208, 208
.  
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4.3.3 Summary 
Vasoconstriction of retinal vessels occurs in hyperoxia which in turn reduces blood flow. The reduction in 
blood flow permits increased oxygen extraction and thus a decrease in retinal SO2. Despite this fact 
however, it is believed that possibly the dissociation of HbO2 is considerably reduced due to the high 
concentration of dissolved oxygen in hyperoxia resulting in an increased retinal SO2. Dissolved oxygen in 
the choroidal circulation also further adds to the high concentration of oxygen in the retina in hyperoxia, 
as oxygen in the choroidal blood diffuses into the retina in larger amounts than in hypoxia 
11, 220-222
. 
Retinsal SO2 increases in hyperoxia are, however, generally restricted as a result of Hb being almost 
100% saturated at normoxia 
168
. Retinal blood SO2 generally increases (non-linearly) with increasing 
oxygen tension (PO2) up to about 100mmHg from where it plateaus as shown in the oxygen dissociation 
curve previously described (Fig 1.4).  
Inter-subject variation of especially retinal SO2 parameters in this pilot study may be due to several 
inherent factors due to the lack of an automated algorithm and thus, the use of a manual analysis 
methodology adopted from Beach and co-workers (1999). For example, the effect of cursor placement of 
the researcher is believed to have played a major role in the analysis. Additionally, choroidal 
pigmentation was not compensated for in this study which included people of Black, Asian, Middle 
Eastern and White backgrounds. Choroidal pigmentation varies among individuals and races, which 
significantly affects the variation in SaO2 among participants 
9
. Vessel diameters have also been reported 
previously to have influence on measurements of hemoglobin SO2 and need to be compensated for in 
future studies 
9
. Also, artifacts from eye movement, reflections from the RPE, the iris and uneven 
illumination due to vessels closer to the periphery of captured images is believed to have had some effect 
on our retinal blood SO2 results. Additional limitations which may have also affected TRBF estimates in 
this study lay in the possibility of leakage in the seal between the participants face and the breathing mask 
used and participant’s refusal to breathe deeply which may have resulted in inadequate targeting of end 
tidal values.  
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To overcome some of these problems the average OD of 6 images (3 9-cubed images and 3 21-cubed 
images) per participant and per provocation step were used. Participants were made as comfortable as 
possible and were also instructed to keep as still as possible while fundus images were taken. The 
participants were also given short breaks in between fundus photos to blink and stretch. Other difficulties 
were, however, inevitable due to technicalities of our prototype and the manual analysis method. Finally, 
due to a smaller sample size all outliers were included in the correlation analysis which could have 
weakened the association. 
The mean ± SD of retinal blood SO2 in the arterioles (SaO2), 95.19% ± 31.04% and in the venules (SvO2), 
53.89% ± 17.24% fell within the range expected and described in the literature. The magnitude of the 
difference between the SaO2 and SvO2 was consistent with the literature and appropriate for a low flow, 
high oxygen exchange vascular system typical of the inner retinal vascular system.TRBF was found in 
this study to relate inversely with SaO2 and SvO2. The inverse relationship reported was consistent with 
current literature. 
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5 Conclusion 
In Chapter 3, the 605/586 wavelength combination out of all the 3 wavelength combinations (605/586, 
600/569 and 610/548) considered in the study showed the overall least variability when measuring ODR 
of retinal vessels close to the optic disk with our prototype HRC device.   
The least variability of the wavelength combinations, that is the 605/586 nm, presupposed that it was the 
most reliable of the three wavelength combinations considered for measuring ODR with the prototype 
HRC used in the study. 
In Chapter 4, the absolute mean retinal blood SO2 at normoxia in the arterioles (SaO2) and venules (SvO2) 
fell within the range described in the literature. The magnitude of the difference between the SaO2 and 
SvO2 (~ 40%) was also consistent with the literature. This magnitude was appropriate for a low flow, high 
oxygen exchange vascular system typical of the inner retinal vascular system. 
Using group data, rather than individual data for each study participant, TRBF was found to relate 
inversely with SaO2 (r = -0.354 and p = 0.001) and SvO2 (r = – 0.295 and p=0.008). This relationship 
between TRBF and SaO2 and SvO2, was as expected based upon data derived primarily from animal 
models. This study is ground-breaking and unique, in that, it is the first study to concomitantly measure 
both retinal blood SO2 and TRBF in human participants. Individual data showed extensive variability and 
noise, thus limiting the strength of the association between TRBF and SaO2 and SvO2. 
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5.1 Future Directions 
5.1.2 Corrections for pigmentation, vessel size, eye movement artifacts and unwanted reflections  
Choroidal pigmentation varies among individuals and races, which will significantly affect the variation 
in retinal SO2 values among participants {{1082 Beach 1999;}}. Choroidal pigmentation should be 
compensated for in future studies in order to calculate ODRs for SO2 measurements. This could be 
possible with the use of an in vitro model comprising of capillary tubes; similar to that of Lemaillet and 
co-workers (2009) to measure phantom optical properties {{998 Lemaillet,P. 2009;}}. This in vitro model 
could be used to model retinal vessels and the fundus environment so as to provide similar artifacts that 
arise from choroidal pigmentation, eye movement, etc. and thus calibrate and provide 
algorithms/correction factors that could be incorporated into the SO2 equations.  
Vessel diameters have also been reported previously to have an influence on measurements of 
hemoglobin SO2 and need to be corrected {{1082 Beach 1999;}}. Future studies should look at 
measuring vessel diameters to evaluate the change in retinal blood SO2 over a series of differing vascular 
reactivity conditions. This change in vascular reactivity may also be compared to that related to TRBF 
changes. Finally, algorithms designed to compensate for eye movement artifacts and unwanted reflections 
should be included in future studies so as to elicit the true SO2 from ODR results acquired from the 
reflectance profile. 
5.1.3 Further Criteria for Selection of Wavelength Combinations for Retinal Oximetry 
A critically important specification for reliable and optimal measurements of optical density in spectral 
analysis techniques such as retinal oximetry is the choice of specific wavelengths. Despite this, there has 
not been any well-defined standard model reported as yet for the determination of the most consistent and 
reliable wavelength pairs for retinal oximetry. 
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Criteria that may be considered in the choice of wavelength combinations might include the absorbance 
characteristics of individual wavelengths. That is, the difference in absorbance between each wavelength 
pair and the mean absorption of light per wavelength combination should be investigated. Also, 
absorption differences between vessels (arterioles/venules) and adjacent tissue may be of interest. 
Reflections from blood vessels and tissue (fundus) diminish as the amount of light absorbed by the 
tissue/vessel increases.  
5.1.1 Quantification of Retinal Blood SO2 in Diseased Retinae 
Failure of the autoregulatory system and VR of the retinal vascular system has been implicated in the 
pathogenesis of several major ocular diseases such as retinopathy of prematurity (ROP), age-related 
macular degeneration (ARMD), diabetic retinopathy (DR) and glaucoma {{1194 HICKAM 1963; 1337 
Wangsa 2003; 1240 Olafsdottir,O.B. 2011; 820 Harris 2003;}}. While limited studies have been 
conducted by other research groups using snapshot techniques (which bleach the photopigments) {{1308 
Hardarson,S.H. 2012; 835 Hardarson,S.H. 2011; 1240 Olafsdottir,O.B. 2011; 1241 Traustason,S. 
2009;}}, there are yet no investigations to determine differences in retinal blood SO2 in diseased retinae 
with the HRC system, so as to provide further validation data for the apparatus.  
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Appendix A: Optical Density Ratio (ODR) Variability with the Image Replicating Imaging 
Spectrometer (IRIS) Hyperspectral Retinal Camera (Photon etc. Inc. Montreal). Flow Chart of 
Procedures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCREENING: VA, IOP, Anterior 
Segment & Van Herrick’s Test  
AIR BREATHING & BASELINE MEASURES:  
(BP, SPO2, Pulse) 
IOP Measurement Repeated 
Pupil Dilation (1% 
Tropicamide) 
TWO SO2 BASELINE MEASURES TAKEN:  
(BP, SPO2, Pulse monitored every 2.5mins) 
FACEMASK ATTACHED TO PARTICIPANT’S FACE  
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Appendix B: Total Retinal Blood Flow and ODR with Gas Provocation Challenge in Healthy 
Participants. Flow Chart of Procedures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HYPEROXIC PROVOCATION PROTOCOL 
FIRST STEP – 200mmHg 
SECOND STEP – 300mmHg 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
THIRD STEP – 400mmHg 
BASELINE (15mins): SO2/RBF,  
Pulse, SPO2, BP measures every 2.5 mins 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
SCREENING: VA, IOP, Anterior Segment & Van Herrick’s Test  
Pupil Dilation (1% Tropicamide) 
AIR BREATHING & BASELINE MEASURES:  
(BP, SPO2, Pulse) 
FACEMASK ATTACHED TO PARTICIPANT’S FACE  
BASELINE (15mins): SO2/RBF,  
Pulse, SPO2, BP measures every 2.5 mins 
BASELINE (5 mins) 
 
BASELINE (5 mins) 
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* Both provocation challenge protocols would be run for the HRC (SO2) followed by the Doppler OCT 
(RBF). To allow for PETO2 of 50mmHg to be reached, gas tanks would need to be changed; as such, both 
SO2 and RBF will be taken with the HRC and Doppler OCT at the same time at this stage 
 
 
 
 
 
 
 
 
HYPOXIC PROVOCATION PROTOCOL 
FIRST STEP – 80mmHg 
SECOND STEP – 60mmHg 
THIRD STEP – 50mmHg 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
SO2/RBF, Pulse, SPO2, BP measures every 2.5 mins 
 
BASELINE (5 mins) 
 
BASELINE (5 mins) 
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400mmHg 300mmHg 
400mmHg 300mmHg 
Appendix C: Hyperoxia and Hypoxia Protocols 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.0 Hyperoxia protocol; PETO2 of 100, 200, 300 and 400mmHg (Above) and hypoxia protocol; PETO2 of 100, 80, 60 
and 50mmHg (below) protocols. Three repeat measurements of TRBF and SO2 were taken at each PETO2 step. 
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